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  To a mixture of CuI (1.10 g, 5.78 mmol.) and diethyl ether (100 mL) at -20 °C was added 1.0 M solution 
of allylmagnesium bromide in diethyl ether (31 mL, 31 mmol) dropwise. After stirring for 30 min, a 
solution of (R)-2-(((4-methoxybenzyl)oxy)methyl)oxirane (5.62 g, 28.9 mmol) in 20 mL of diethyl ether 
was added to the reaction mixture. After another 1 h of stirring, 30 mL of saturated ammonium chloride 
solution was added to the reaction mixture and it was warmed to 25 °C. After the aqueous phase turned 
dark blue, the organic phase was separated and the aqueous phase was extracted with 100 mL of diethyl 
ether three times. The organic extracts were combined, dried over sodium sulfate, and filtered. Evaporation 
of the filtrate gave a light yellow oil which was then dissolved in 80 mL of THF. The solution was cooled 
to 0 °C and 2.2 g of a 60% suspension of NaH in mineral oil was added. The mixture was warmed to 25 °C 
and stirred for 1 h. After the reaction mixture was re-cooled to 0 °C, tetra-n-butylammonium bromide (0.50 
g, 1.3 mmol) and benzyl bromide (4.2 mL, 35 mmol) were added and the reaction mixture was warmed to 
25 °C. After stirred for 16 h, 2 mL of methanol followed by 20 mL of saturated aqueous ammonium 
chloride solution were added. After the mixture was warmed to room temperature, THF was evaporated 
and the aqueous mixture was extracted with 120 mL of diethyl ether four times. The combined organic 
phase was washed with brine, dried over Na2SO4, filtered and concentrated.  The residue was purified by 
flash chromatography (hexanes: EtOAc, 15:1, v/v) to give a colorless oil (7.80 g, 23.9 mmol, 84%, two 
steps):  Rf 0.60 (hexanes-ethyl acetate, 8:1, v/v); [α]D20  +10.1 (c 0.50, CHCl3); IR (neat): 3024, 2927, 2860, 
1719, 1510, 1454, 1246, 1089, 1039, 822 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.33 (m, 5H), 7.28 (d, J = 
8.5 Hz, 2H), 6.88 (d, J = 8.5 Hz, 2H), 5.79 (m, 1H), 5.00 (d, J = 12 Hz, 1H), 4.95 (d, J = 10 Hz, 1H), 4.68 
(d, J = 12 Hz, 1H), 4.55 (d, J = 12 Hz, 1H), 4.49 (s, 2H), 3.81 (s, 3H), 3.60 (m, 1H), 3.55 (dd, J = 10, 4.5 
Hz, 1H), 3.50 (dd, J = 10, 4.5 Hz, 1H), 2.15 (m, 2H), 1.66 (m, 2H) ); 13C NMR (CDCl3, 125 MHz) δ 159.2, 
138.9, 138.5, 130.5, 129.2, 128.3, 127.8, 127.5, 114.7, 113.8, 77.6, 73.0, 72.5, 72.0, 55.3, 31.3, 29.7; 







  To a mixture of (R)-1-(((2-(Benzyloxy)hex-5-en-1-yl)oxy)methyl)-4-methoxybenzene (6.80 g, 20.8 
mmol), CH2Cl2 (120 mL) and methanol (60 mL) at -78 °C was treated with ozone until a light blue color 
persisted. The excess ozone was then displaced with argon and triphenylphosphine (5.47 g, 20.8 mmol) was 
added. The reaction mixture was warmed to 25 °C and stirred for 2 h more. The solvent was then 
evaporated and the residue was purified by chromatography (hexanes: ethyl acetate, 6:1, v/v) to provide 13 
(5.70 g 17.3 mmol, 83%) as a colorless oil:  
  Rf 0.46 (hexanes-ethyl acetate, 4:1, v/v); [α]D20 +23.2 (c 0.44, CHCl3); IR (neat): 3024, 2927, 2860, 1719, 
1510, 1454, 1246, 1089, 1039, 822 cm-1; 1H NMR (CDCl3, 500 MHz): δ 9.71 (t, J = 1.5 Hz, 1H), 7.33 (m, 
5H), 7.25 (d, J = 8.5 Hz, 2H), 6.88 (d, J = 8.5 Hz, 2H), 4.66 (d, J = 11.5 Hz, 1H), 4.50 (d, J = 11.5 Hz, 1H), 
4.47 (s, 2H), 3.81 (s, 3H), 3.60 (m, 1H), 3.55 (dd, J = 10, 4.5 Hz, 1H), 3.48 (dd, J = 10, 4.5 Hz, 1H), 2.49 
(m, 2H), 1.91(m, 2H); ); 13C NMR (CDCl3, 125 MHz) δ 202.3, 159.3, 138.4, 130.2, 129.3, 128.4, 127.9, 
127.7, 113.8, 76.8, 73.1, 72.0, 71.9, 55.3, 40.0, 24.8; HRMS calcd for C21H28O5Na [M + Na+CH3OH]+: 







(4S,7R)-7-(Benzyloxy)-8-((4-methoxybenzyl)oxy)-2-methyloct-1-en-4-ol  (14) 
  A mixture of (R)-(+)-1,1’-bi-2-naphthol (0.430 g, 1.50 mmol), Ti(Oi-Pr)4 (0.44 mL, 1.50 mmol) and oven-
dried powdered 4Å molecular sieves (7.2 g) in CH2Cl2 (20 mL) was heated at reflux for 1 h. The red-brown 
mixture was cooled to room temperature and a solution of 13 (4.25 g, 12.9 mmol) in CH2Cl2 (10 mL) was 
added. After being stirred for 10 min, the contents were cooled to -78 °C, and 2-methyl-allyl tri-n-
butylstannane (6.00 g, 17.4 mmol) was added. The reaction was stirred for 10 min then placed in a -20 °C 
freezer for 72 h.  A solution of saturated NaHCO3 (4 mL) was added and the mixture was stirred for 1 h.  
Na2SO4 (6.0 g, 42.2 mmol) was then added and the mixture was filtered through a plug of Celite and 
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concentrated. The residue was purified by flash chromatography (hexanes-EtOAt, 4:1, v/v) to give 14 as a 
light yellow oil (4.98 g, 12.9 mmol, quant.):  
  Rf 0.32 (hexanes-ethyl acetate, 4:1, v/v); IR (neat): 3444, 3067, 3022, 2918, 2856, 1644, 1614, 1586, 
1454, 1302, 1247, 1173, 1089, 891, 739, 698 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.32 (m, 5H), 7.27 (d, J 
= 8.5 Hz, 1H), 6.88 (d, J = 8.5 Hz, 1H), 4.87 (s, 1H), 4.78 (s, 1H), 4.70 (d, J = 11.5 Hz, 1H), 4.57 (d, J = 
11.5 Hz, 1H), 4.49 (s, 2H), 3.81(s, 3H), 3.70 (m, 1H), 3.63 (m, 1H), 3.57 (dd, J = 10, 5 Hz, 1H), 3.52 (dd, J 
= 10, 5 Hz, 1H), 2.14 (m, 2H), 1.99 (brs, 1H), 1.77 (m,1H), 1.76 (s, 3H), 1.64 (m, 2H), 1.47 (m, 1H). 13C 
NMR (CDCl3, 125 MHz) δ 159.2, 142.9 138.8, 130.5, 129.3, 128.3, 127.9, 127.5, 113.8, 113.3, 78.3, 77.3, 







(2R,5S)-2-(Benzyloxy)-7-methyloct-7-ene-1,5-diol  (15) 
  To a mixture of 14 (2.00g, 5.20 mmol), tert-butanol (1.0 mL), pH = 7 buffer (4.0 mL) and CH2Cl2 (40 ml) 
at 25 °C was added 2,3-dichloro-5,6-dicyanobenzoquinone (1.77 g, 7.80 mmol). The mixture was stirred 
for 2 hours before a saturated NaHCO3 solution (80 mL) was added. The mixture was then diluted with 100 
mL of diethyl ether and the organic phase was separated. The aqueous phase was further extracted with 
diethyl ether (5×50 mL) and the combined organic phase was dried over Na2SO4, filtered and concentrated. 
The residue was purified by chromatography (hexanes-EtOAc, 1:1, v/v) to give 15 (1.09 g, 4.16 mmol, 
80%) as a light pink oil.  
  Rf 0.25 (hexanes-ethyl acetate, 1:1, v/v); IR (neat): 3390, 3070, 3031, 2930, 2872, 1645, 1454, 1381, 
1346, 1207, 1067, 890, 738, 698 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.36 (d, J = 4.5 Hz, 4H), 7.30 (m, 
1H), 4.89 (t, J = 1.5 Hz, 1H), 4.79 (d, J = 1 Hz, 1H), 4.63 (d, J = 11.5 Hz, 1H), 4.57 (d, J = 11.5 Hz, 1H), 
3.71 (m, 2H), 3.57 (m, 2H), 2.18 (dd, J = 13, 3.5 Hz, 1H), 2.11 (dd, J = 13, 9 Hz, 1H), 1.95 (brs, 1H), 1.87 
(brs, 1H), 1.75 (s, 3H), 1.73 (m, 1H), 1.60 (m, 1H), 1.50 (m, 1H); 13C NMR (CDCl3, 125 MHz) δ 142.6, 
138.4, 128.5, 127.9, 127.8, 113.6, 79.7, 71.6, 68.7, 64.2, 46.2, 32.7, 27.1, 22.4; HRMS calcd for 









  To a solution of 15 (0.90 g, 3.40 mmol) in CH2Cl2 (30 mL) was added iodobenzene diacetate (2.74 g, 8.51 
mmol) and 2,2,6,6-tetramethylpiperidine-1-oxyl (0.0265 g, 0.170 mmol). The reaction mixture was stirred 
for 12 h before saturated Na2S2O3 solution (10 mL) was added. Diethyl ether (60 mL) was then added to the 
mixture and the organic phase was separated. The aqueous phase was then extracted with diethyl ether (3 × 
20 mL). The combined organic phase was washed with brine, dried over Na2SO4, concentrated and purified 
by flash chromatography (hexanes-ethyl acetate, 8:1, v/v) to give compound 16 (0.75 g, 4.61 mmol, 83%) 
as a colorless oil.  
  Rf 0.36 (hexanes-ethyl acetate, 8:1, v/v); [α]D20 +96.0 (c 0.31, CHCl3); IR (neat): 3074, 3031, 2936, 2860, 
1747, 1650, 1454, 1378, 1312, 1249, 1192, 1129, 1057, 895, 738, 700 cm-1 1H NMR (CDCl3, 500 MHz): δ 
7.37 (m, 5H), 4.91 (d, J = 12 Hz, 1H), 4.86 (s, 1H), 4.78 (s, 1H), 4.71-464 (m, 1H), 4.67 (d, J = 12 Hz, 1H), 
3.96 (dd, J = 7, 5 Hz, 1H), 2.47 (dd, J = 12, 8 Hz, 1H), 2.24 (dd, J = 12, 6 Hz, 1H), 2.16 (m, 1H), 2.00 (m, 
2H), 1.96 (s, 3H), 1.61 (m, 1H); 13C NMR (CDCl3, 125 MHz) δ 171.0, 140.4, 137.4, 128.5, 128.1, 128.0, 







  To a solution of 16 (0.68 g, 2.61 mmol) in CH2Cl2 (22 mL) at -78 °C was added diisopropylaluminum 
hydride (1 M in toluene, 3.13 mL 3.13 mmol) dropwise. The solution was gradually warmed to -40 °C and 
was stirried at this temperature for 1 h. Methanol (1 mL), saturated sodium potassium tartrate solution (20 
mL) and diethyl ether (30 mL) was added to the reaction mixture in sequence. The mixture was warmed to 





diethyl ether (4  × 20 mL). The organic extracts were combined, dried over Na2SO4, filtered and 
concentrated. The colorless residue was then dissolved in 14 mL of dry dichloromethane. Imidazole 
(0.444g, 6.53 mmol), 4-dimethylaminopyridine (0.032 g, 0.261 mmol) and tert-butyldimethylchlorosilane 
(0.473g, 3.13 mmol) were also added to the solution in sequence. The mixture was stirred for 3 h before 
saturated NH4Cl solution (10 mL) and diethyl ether (20 mL) were added. The organic phase was separated 
and the aqueous phase was extracted with diethyl ether (3 × 10 mL). The combined organic phase was 
dried over Na2SO4, filtered, and concentrated. The residue was purified by flash chromatography (hexanes-
ethyl acetate, 30:1, v/v) to give 17 as a colorless oil (0.980 g, 2.60 mmol, 99%, two steps): 
  Rf 0.50 (hexanes-ethyl acetate, 20:1, v/v); [α]D25 = -4.8 (c 1.25, CHCl3); IR (neat): 3074, 3030, 2929, 
2888, 2856, 1452, 1391, 1292, 1250, 1167, 1099, 1068, 1005, 892, 836, 733, 697 cm-1; 1H NMR (CDCl3, 
500 MHz): δ 7.33 (m, 5H), 4.82 (d, J = 12 Hz, 1H), 4.77 (s, 1H), 4.73 (s, 1H), 4.65 (d, J = 12 Hz, 1H), 4.56 
(d, J = 7 Hz, 1H), 3.54 (m, 1H), 3.16 (ddd, J = 12, 7, 5 Hz, 1H), 2.28 (dd, J = 14, 8 Hz, 1H), 2.12 ( dd, J = 
14, 5 Hz, 1H), 2.02 (m, 1H), 1.74 (s, 3H), 1.62 (m, 1H), 1.48 (m, 1H), 1.32 (m, 1H), 0.94 (s, 9H), 0.14 (d, J 
= 3.5 Hz, 6 H); 13C NMR (CDCl3, 125 MHz) δ 142.2, 139.1, 128.3, 127.7, 127.4, 112.6, 100.2, 78.2, 74.0, 
72.7, 74.0, 72.7, 43.9, 30.7, 29.2, 25.8, 22.7, 18.1, -4.0, -5.1; HRMS calcd for C22H36O3SiNa [M + Na]+: 











  To a mixture of 17 (0.940 g, 2.50 mmol), tert-butanol (12.5 mL) and water (12.5 mL) at 0 °C was added 
AD-mix-α (3.5 g). The mixture was stirred vigorously for 48 h then sodium sulfite (4.0 g) was added. The 
mixture was stirred at 25 °C for 1 h before 20 mL diethyl ether was added. The organic phase was 
separated and the aqueous phase was extracted with diethyl ether (4 × 15 mL). The combined organic phase 
was dried over Na2SO4, filtered and concentrated. The residue was purified through column 
chromatography (hexanes-ethyl acetate, 4:1 to 2:1 to 1:1, v/v) to give 18 (0.701 g, 1.71 mmol, 68%) and 
18a (0.236 g, 0.575 mmol, 23%) as colorless oils.  Data for 18: 
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  Rf 0.20 (hexanes-ethyl acetate, 2:1, v/v); [α]D25 +6.7 (c 0.34, CHCl3); IR (neat): 3415, 2929, 2857, 1650, 
1454, 1392, 1252, 1170, 835 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.33 (m, 5H), 4.73 (d, J = 12 Hz, 1H), 
4.62 (d, J = 12 Hz, 1H), 4.59 (d, J = 7 Hz, 1H), 3.76 (m, 1H), 3.57 (dd, J = 11, 5 Hz, 1H), 3.43 (dd, J = 11, 
8 Hz, 1H), 3.41 (s, 1H), 3.14 (ddd, J = 12, 7, 4.5 Hz, 1H), 2.29 (m, 1H), 2.04 (m, 1H), 1.81 (dd, J = 14, 8.5 
Hz, 1H), 1.69 (dd, J = 14, 4 Hz, 1H), 1.59 (m, 1H), 1.51-1.36(m, 2H), 1.18 (s, 3H), 0.92 (s, 9H), 0.15 (s, 
3H), 0.14 (s, 3H); 13C NMR (CDCl3, 125 MHz) δ 138.7, 128.3, 127.7, 127.5, 99.3, 78.0, 73.7, 72.5, 72.3, 
69.3, 43.6, 31.7, 28.8, 25.7, 25.6, 25.2, 17.9, -4.5, -4.9; HRMS calcd for C22H38O5SiNa [M + Na]+: 










  To a solution of 18 (0.560 g, 1.36 mmol) in CH2Cl2 (10 mL) was added 2,2-dimethoxypropane (1.01 mL, 
0.852 g, 8.18 mmol) followed by pyridinium p-toluenesulfonate (18.3 mg, 0.068 mmol). The reaction 
mixture was stirred for 2.5 h before 0.5 mL of triethylamine was added. The solvent was evaporated and 
the residue was filtered through a pad of silica gel with hexanes-ethyl acetate (4:1, v/v). The obtained 
solution was concentrated and the residue was dissolved in THF (10 mL) and was treated with tetra-n-
butylammonium fluoride solution (1.0 M in THF, 1.43 mL, 1.43 mmol) dropwise within 1 h. The mixture 
was stirred for another 0.5 h before saturated ammonium chloride solution (5 mL) was added. THF was 
removed from the mixture and diethyl ether (20 mL) was added. The mixture was stirred for 10 min and the 
organic phase was separated. The aqueous phase was extracted with diethyl ether (3 × 15 mL). The 
combined organic phase was dried over Na2SO4, filtered and concentrated. The residue was filtered through 
a pad of silica gel with hexanes-ethyl acetate (2:1, v/v) and the obtained solution was concentrated. The 
residue was dissolved in CH2Cl2 (10 mL) followed by addition of NaHCO3 (0.40 g, 4.82 mmol), 
iodobenzene diacetate (0.526 g, 1.63 mmol) and 2,2,6,6-tetramethylpiperidine-1-oxyl (12.0 mg, 0.077 
mmol). The reaction was stirred for 12 h before saturated Na2S2O3 solution (3.0 mL) was added. Diethyl 
ether (20 mL) was added to the mixture and organic phase was separated. The aqueous phase was then 
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extracted with diethyl ether (3 × 15 mL). The combined organic phase was washed with brine, dried over 
Na2SO4, concentrated and purified by flash chromatography (hexanes: ethyl acetate, 4:1, v/v) to give 
compound 10 (0.370 g, 1.11 mmol, 82%, three steps) as a colorless oil. 
  Rf 0.34 (hexanes-ethyl acetate, 4:1, v/v); [α]D25 +80.0 (c 0.40, CHCl3); IR (neat): 3058, 3028, 2928, 2930, 
2868, 1745, 1454, 1379, 1246, 1209, 1118, 1058, 806, 739, 699 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.36 
(m, 5H), 4.89 (d, J = 12 Hz, 1H), 4.73 (m, 1H), 4.66 (d, J = 12 Hz, 1H), 3.95 (dd, J = 7.5, 5 Hz, 1H), 3.86 
(d, J = 9 Hz, 1H), 3.80 (d, J = 9 Hz, 1H), 2.12 (m, 1H), 2.02 (m, 2H), 1.92 (dd, J = 14, 8.5 Hz, 1H), 1.84 
(dd, J = 14, 4 Hz, 1H), 1.38(s, 3H), 1.35(s, 6H); 13C NMR (CDCl3, 125 MHz) δ 170.6, 137.4, 128.5, 128.1, 
128.0, 109.0, 79.6, 77.3, 46.0, 28.3, 27.2, 27.1, 26.6, 24.2; HRMS calcd for C19H26O5Na [M + Na]+: 






  To a solution of 19[1] (0.885 g, 3.56 mmol), imidazole (0.389 g, 5.70 mmol) and 4-dimethylaminopyridine 
(0.0435 g, 0.356 mmol) in CH2Cl2 (15 mL) was added chlorotriethylsilane (0.590 g, 0.66 mL, 3.92 mmol). 
The mixture was stirred for 30 min before saturated NH4Cl solution (6 mL) and diethyl ether (20 mL) were 
added. The organic phase was separated and the aqueous phase was extracted by diethyl ether (3 × 10 mL). 
The organic extracts were combined, dried over Na2SO4, filtered and concentrated. The residue was 
purified by flash column chromatography (hexanes: ethyl acetate, 16:1, v/v) to give 20 (1.290 g, 
quantitative) as a colorless oil. 
  Rf 0.66 (hexanes-ethyl acetate, 8:1, v/v); [α]D25 +19.0 (c 0.64, CHCl3); IR (neat): 3310, 2955, 2910, 2876, 
2119, 1613, 1514, 1462, 1247, 1085, 1007, 822, 742; 1H NMR (CDCl3, 500 MHz): δ 7.25 (m, 2H), 6.87 
(m, 2H), 4.44 (d, J = 6.5 Hz, 1H), 4.40 (d, J = 6.5 Hz, 1H), 3.84 (q, J = 5.5 Hz, 1H), 3.81 (s, 3H), 3.51 (dd, 
J = 9, 5.5 Hz, 1H), 3.33(dd, J = 9, 6 Hz, 1H), 2.42 (ddd, J = 17, 6, 3 Hz, 1H), 2.33 (ddd, J = 17, 6, 3 Hz, 
1H), 2.11 (m, 1H), 1.96 (t, J = 3 Hz, 1H), 0.96 (t, J = 8 Hz, 1H), 0.61 (q, J = 8 Hz, 1H); 13C NMR (CDCl3, 
125 MHz) δ 159.0, 130.9, 129.1, 113.7, 81.9, 72.6, 72.5, 71.7, 69.8, 55.3, 38.5, 24.8, 13.8, 6.9, 5.1; HRMS 














  To a stirred -78 °C solution of 20 (0.976 g, 2.69 mmol) in THF (15 mL) was added n-butyllithium (1.0 
mL of a 2.5 M solution in hexanes, 2.5 mmol). After the mixture was stirred for 40 min, a solution of 10 
(0.360 g, 1.07 mmol) in THF (5 mL) was added via cannula. After one hour, saturated aqueous NH4Cl 
solution (15 mL) was added and the mixture was warmed to room temperature. The mixture was extracted 
with diethyl ether (3×50 mL) and the combined organic extracts were washed with water and saturated 
aqueous NaCl. The combined organic fraction was dried over Na2SO4, filtered and concentrated. The 
residue was chromatographed on silica gel (hexanes-ethyl acetate, 5:1, v/v) to give 21 (0.725 g, 1.05 mmol, 
99%) as colorless oil. 
  Rf 0.42 (hexanes-ethyl acetate, 4:1, v/v); [α]D25 +42.9 (c 0.55, CHCl3); IR (neat): 3438, 3059, 3034, 2953, 
2875, 2209, 1672, 1613, 1513, 1371, 1247, 1082, 822, 741 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.33 (m, 
5H), 7.23 (d, J = 7 Hz, 2H), 6.86 (d, J = 7 Hz, 2H), 4.73 (d, J = 12 Hz, 1H), 4.42 (d, J = 12 Hz, 1H), 4.37 
(d, J = 12 Hz, 2H), 3.91 (m, 2H), 3.82 (d, J = 8.5 Hz, 1H), 3.79 (s, 3H), 3.71 (d, J = 8.5 Hz, 1H), 3.45 (dd, J 
= 9, 6 Hz, 1H), 3.32 (dd, J = 9.5, 5.5 Hz, 1H), 3.10 (d, J = 2 Hz, 1H), 2.65 (dd, J = 17, 6 Hz, 1H), 2.53 (dd, 
J = 17, 6 Hz, 1H), 2.08 (m, 1H), 1.99 (m, 1H), 1.72-1.45 (m, 6H), 1.43 (s, 3H), 1.40 (m, 1H), 1.37 (s, 3H), 
1.32 (m, 2H), 1.29 (s, 3H), 0.94 (m, 12H), 0.60 (q, J = 8 Hz, 6H); 13C NMR (CDCl3, 125 MHz) δ 189.0, 
159.1, 137.4, 130.6, 129.1, 128.5, 128.1, 127.9, 127.7, 113.7, 109.2, 95.6, 84.9, 81.3, 80.5, 73.5, 72.7, 72.3, 
71.9, 71.4, 68.1, 55.3, 45.3, 38.8, 33.6, 28.3, 27.6, 26.8, 26.7, 25.6, 13.6, 6.9, 5.0; HRMS calcd for 













  To a solution of 21 (0.60 g, 0.861 mmol) in CH2Cl2 (16 mL) at 0 °C was added triethylamine (0.47 mL, 
3.35 mmol), followed by chlorotrimethylsilane (0.15 mL, 1.18 mmol) and 4-dimethylaminopyridine (6 mg, 
0.050 mmol). After stirring for 50 min, saturated aqueous NH4Cl solution (5 mL) was added. The mixture 
was extracted with diethyl ether (3 × 25 mL) and the combined organic phases were washed with water and 
saturated aqueous NaCl (10 mL), dried over Na2SO4, filtered, and concentrated. The residue was directly 
used for next step without further purification. 
  To a -78 °C suspension of CuI (0.984 g, 5.17 mmol) in diethyl ether (4 mL) under argon was added 
methyllithium (6.9 mL of a 1.5 M solution in diethyl ether, 10.3 mmol). The mixture was allowed to warm 
slowly to -30 °C until a clear and colorless solution formed. The solution was cooled to -78 °C, and a 
solution of crude TMS-protected 21 in diethyl ether (4 mL) was added via cannula. After 1.0 h, saturated 
aqueous NH4Cl (10 mL) was added and the mixture was warmed to room temperature and stirred until the 
aqueous became bright blue. The solution was extracted the diethyl ether (3 × 25 mL) and the combined 
organic phases were washed with water and saturated aqueous NaCl (10 mL), dried over Na2SO4, filtered, 
and concentrated to give a crude enone product which was then dissolved in the mixture of 
dichloromethane (16 mL) and methanol (7 mL), and pyridinium p-toluenesulfonate (11.6 mg, 0.0431 
mmol). After the solution was stirred at 25 °C for 2 h, triethylamine (0.50 mL) was added. After the 
mixture was stirred for 10 min, the solvent was removed and the residue was purified via chromatography 
(hexanes-ethyl acetate, 8:1 to 6:1, v/v) to give 23 (0.185 g, 0.319 mmol, 37% based on 21) as colorless oil. 
  Rf 0.42 (hexanes-ethyl acetate, 4:1, v/v); [α]D25 +11.8 (c 0.70, CDCl3); IR (neat): 3058, 3026, 2931, 2862, 
1609, 1521, 1250, 1098 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.26 (m, 7H), 6.86 (d, J = 7 Hz, 2H), 5.15 (s, 
1H), 4.61(d, J = 12 Hz, 1H), 4.48 (d, J = 12 Hz, 1H), 4.43 (d, J = 4 Hz, 1H), 3.78(m, 2H), 3.78(s, 3H), 3.72 
(m, 1H), 3.65 (m, 2H), 3.35 (dd, J = 9, 8 Hz, 1 H), 3.24 (dd, J = 11.5, 8.5, 1H), 2.08 (m, 1H), 2.01(m, 1H), 
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1.92 (qd, J = 12.5, 3 Hz, 1H), 1.80 (m, 2H), 1.73 (s, 3H), 1.66(m, 2H), 1.36 (s, 3H), 1.32 (s, 3H), 1.24 (s, 
3H), 1.00 (d, J = 7, 1H); 13C NMR (CDCl3, 125 MHz) δ 159.1, 139.0, 136.9, 130.9, 129.2, 128.1, 127.8, 
127.4, 123.0, 113.7, 108.2, 95.9, 80.4, 78.8, 77.2, 75.0, 72.7, 72.2, 71.3, 69.8, 66.2, 55.3, 46.2, 38.5, 32.8, 











  To a mixture of 23 (30 mg, 51 µmol), CH2Cl2 (5.0 mL), an aqueous NaH2PO4 buffer (pH = 7, 1.0 mL), 
and tert-butyl alcohol (0.30 mL) was added 2,3-dichloro-5,6-dicyanobenzoquinone (70 mg, 0.31 mmol). 
The reaction flask was placed in an aqueous bath and sonicated for 5 min. The mixture was diluted with 
diethyl ether (8 mL) and washed with saturated aqueous NaHCO3 solution (2 mL). The aqueous phase was 
extracted with diethyl ether (3 × 2 mL) and the combined organic phases were washed with saturated 
aqueous NaCl (1.5 mL), dried over Na2SO4, filtered, and concentrated. The residue was purified by silica 
gel column chromatography (hexanes−ethyl acetate, 5:1 to 3:2, v/v) to give a colorless oil which was then 
dissolved in CH2Cl2 (3.0 mL). The solution was added NaHCO3 (150 mg, 1.8 mmol) followed by the 
Dess−Martin periodinane reagent  (80 mg, 0.19 mmol). The mixture was stirred for 30 min before diethyl 
ether (4.0 mL) and 10% aqueous Na2S2O3 and saturated aqueous NaHCO3 (1.0 mL ea.) were added. The 
mixture was stirred until the organic phase became clear and colorless. The separated aqueous phase was 
extracted with diethyl ether (3 × 2 mL), and the combined organic fractions were washed with saturated 
aqueous NaCl (1 mL), dried over Na2SO4, filtered, and concentrated. Silica gel column chromatography 
(hexanes−ethyl acetate, 5:1, v/v) of the residue gave 5 (22 mg, 45 µmol, 90%) as a white crystalline solid. 
   Rf 0.31 (hexanes-ethyl acetate, 4:1, v/v); [α]D25 +29.2 (c 0.42, CDCl3); IR (neat): 3080, 3061, 3030, 2972, 
2928, 2864, 1726, 1453, 1378, 1244, 1206, 1174, 1092, 1053, 1002, 977, 926, 856, 805, 735, 697 cm-1; 1H 
NMR (CDCl3, 500 MHz): δ 9.98 (d, J = 2 Hz, 1H), 7.33-7.24 (m, 5H), 5.17 (s, 1H), 4.61 (d, J = 12.5 Hz, 
1H), 4.47 (d, J = 12.5 Hz, 1H), 4.03 (ddd, J = 11.5, 8.5, 3 Hz, 1H), 3.85-3.79 (m, 2H), 3.67 (d, J = 8.5 Hz, 
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1H), 3.24 (dd, J = 11.5, 5 Hz, 1H), 2.70 (m, 1H), 2.10 (m, 1H), 1.92-1.81 (m, 3H), 1.75 (s, 3H), 1.72-1.61 
(m, 3H), 1.37 (s, 3H), 1.33 (s, 3H), 1.31 (s, 3H), 1.11 (d, J = 7 Hz, 3H); 13C NMR (CDCl3, 125 MHz) δ 
204.5, 138.7, 136.1, 128.2, 127.8, 127.5, 123.3, 108.4, 96.1, 80.3, 78.5, 75.2, 71.4, 69.7, 66.7, 50.5, 45.8, 








(3S,4S)-3,5-bis(Benzyloxy)-4-methylpentan-1-oxyl 4-methoxybenzyl ether (27) 
  To a 0 °C solution of 26[2] (5.61 g, 13.1 mmol) in THF (120 mL) was added NaBH4 (2.48 g, 65.7 mmol) 
followed by water (15 mL). The mixture was stirred for 14 h before saturated NH4Cl solution (30 mL) was 
added. The mixture was stirred for another 1 h before THF was removed via rotary evaporation. The 
aqueous phase was extracted with diethyl ether (4 × 50 mL) and the combined organic phase was dried 
over Na2SO4, filtered and concentrated. The residue was dissolved in THF (110 mL). After the solution was 
cooled to 0 °C, NaH (60% in mineral oil, 2.78 g, 69.4 mmol) was added. The reaction mixture was warmed 
to room temperature and was stirred for 1 h. After the reaction mixture was cooled to 0 °C, benzyl bromide 
(9.97 g, 6.9 mL, 57.8 mmol) and tetra-n-butylammonium iodide (4.27 g, 11.6 mmol) were added. The 
mixture was warmed to room temperature and stirred for 72 h before methanol (3 mL) was added. The 
mixture was stirred for another 1 h before saturated NH4Cl solution (20 mL) was added. THF was removed 
by rotary evaporation and the aqueous phase was extracted with diethyl ether (4 × 50 mL). The combined 
organic phase was dried over Na2SO4, filtered, and concentrated. Silica gel column chromatography 
(hexanes-ethyl acetate, 10:1, v/v) of the residue gave products 27 (3.79 g, 8.73 mmol, 67%) and 26 (1.74 g, 
31%).  Data for 27: 
  Rf 0.39 (hexanes-ethyl acetate, 8:1, v/v); [α]D25 -17.0 (c 0.70, CHCl3); IR (neat): 3080, 3057, 3027, 2921, 
2856, 1613, 1513, 1454, 1362, 1302, 1248, 1092, 820, 736, 697 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.33-
7.21 (m, 12H), 6.86 (m, 2H), 4.47 (m, 4H), 4.42 (d, J = 12 Hz, 1H), 4.38 (d, J = 12 Hz, 1H), 3.80 (s, 3H), 
3.73 (m, 1H), 3.53 (m, 3H), 3.34 (dd, J = 9, 7 Hz, 1H), 2.03 (m, 1H), 1.82 (m, 2H), 0.97 (d, J = 7 Hz, 1H); 
13C NMR (CDCl3, 125 MHz): δ 159.2, 139.1, 138.7, 130.7, 129.3, 128.3, 128.3, 127.7, 127.6, 127.5, 127.4, 
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113.8, 77.2, 73.0, 72.7, 72.6, 72.5, 67.0, 55.3, 37.2, 32.1, 12.1; HRMS calcd for C28H34O4Na [M + Na]+: 







  To a mixture of 27 (2.64 g, 6.07 mmol), 1.0 mL tert-butanol, 5.0 mL pH = 7 buffer and dichloromethane 
(50 mL) at 25 °C was added 2,3-dichloro-5,6-dicyanobenzoquinone (3.18 g, 14.0 mmol). The mixture was 
stirred for 2 h before saturated NaHCO3 (50 mL) solution was added. The mixture was then diluted with 
diethyl ether (100 mL) and the organic phase was separated. The aqueous phase was further extracted with 
diethyl ether (3 × 50 mL) before the combined organic phase was dried over Na2SO4, filtered and 
concentrated. The residue was purified by flash chromatography (hexanes-ethyl acetate, 1:1, v/v) to give 
the product (1.80 g, 5.72 mmol, 94%) as a light yellow oil.  
  Rf 0.16 (hexanes-ethyl acetate, 4:1, v/v); [α]D25 -20.0 (c 0.64, CHCl3); IR (neat): 3407, 3084, 3056, 3029, 
2921, 2874, 1496, 1454, 1362, 1206, 1066, 1028, 736, 697 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.35-7.27 
(m, 10H), 4.58 (d, J = 11.5 Hz, 1H), 4.53 (d, J = 11.5 Hz, 1H), 4.49 (s, 2H), 3.74 (m, 3H), 3.56 (dd, J = 9, 6 
Hz, 1H), 3.36 (dd, J = 9, 6.5 Hz, 1H), 2.12 (m, 1H), 2.05 (brs, 1H), 1.77 (m, 2H), 1.01 (d, J = 7 Hz, 3H); 
13C NMR (CDCl3, 125 MHz): δ 138.6, 138.5, 128.4, 128.4, 127.9, 127.7, 127.7, 127.6, 79.2, 73.2, 72.3, 







(3S, 4S)-3,5-Bis(benzyloxy)-4-methylpentanal (28)  
  To a 0 °C solution of (3S,4S)-3,5-bis(benzyloxy)-4-methylpentan-1-ol (1.80 g, 5.72 mmol) in 
dichloromethane (30 mL) was added DMSO (2.5 mL), diisopropylethylamine (6.0 mL) and sulfur trioxide 
pyridine complex (2.00 g, 12.6 mmol). The solution was stirred for 1 h at 0 °C before saturated NH4Cl 
solution (8 mL) and diethyl ether (60 mL) were added. The mixture was stirred for 5 min before the organic 
phase was separated. The aqueous phase was extracted with diethyl ether (3 × 30 mL). The combined 
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organic phase was dried over Na2SO4, filtered, and concentrated. Silica gel column chromatography 
(hexanes-ethyl acetate, 10:1, v/v) of the residue gave product 28 (1.67 g, 5.34 mmol, 93%). 
  Rf 0.61 (hexanes-ethyl acetate, 4:1, v/v); [α]D25 -2.2 (c 0.67, CHCl3); IR (neat): 3082, 3062, 3029, 2963, 
2910, 2856, 2726, 1723, 1487, 1454, 1369, 1204, 1091, 736, 697 cm-1; 1H NMR (CDCl3, 500 MHz): δ 9.77 
(dd, J = 1.5, 1 Hz, 1H), 7.37-7.27 (m, 10H), 4.56 (d, J = 12 Hz, 1H), 4.52 (d, J = 12 Hz, 1H), 4.49 (d, J = 
12 Hz, 1H), 4.46 (d, J = 12 Hz, 1H), 4.14 (m, 1H), 3.52 (m, 1H), 3.40 (m, 1H), 2.74 (m, 1H), 2.58 (m, 1H), 
2.07 (m, 1H), 1.00 (d, J = 7 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ 201.5, 138.4, 128.4, 128.4, 127.7, 









  Procedure Reference: Altmann, K. H.; Bold, G.; Caravatti, G.; Denni, D.; Florsheimer, A.; Schmidt, A.; 
Rihs, G.; Wartmann, M. “ The total synthesis and biological assessment of trans-epothilone A” Helv. Chim. 
Act. 2002, 85, 4086. 
  Rf 0.38 (hexanes-ethyl acetate, 4:1, v/v); [α]D25 +56.4 (c 0.75, CHCl3); IR (neat): 3021, 2930, 2857, 1779, 
1696, 1454, 1385, 1210, 1100, 737, 699 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.34-7.26 (m, 8H), 7.20 (d, J 
= 7.5 Hz, 1H), 4.64 (m, 1H), 4.49 (s, 2H), 4.12 (m, 2H), 3.75 (tq, J = 7, 7 Hz, 1H), 3.47 (m, 2H), 3.26 (dd, J 
= 13.5, 3.5 Hz, 1H), 2.76 (dd, J = 13.5, 9.5 Hz, 1H), 1.84 (m, 2H), 1.67 (m, 1H), 1.24 (d, J = 7 Hz, 1H); 13C 
NMR (CDCl3, 125 MHz): δ 177.0, 153.0, 138.6, 135.4, 129.5, 128.9, 128.4, 127.6, 127.5, 127.3, 77.2, 72.9, 











  To methanol (70 mL) at 0 °C was added methylmagnesium bromide (1 M in diethyl ether, 18.9 mL, 18.9 
mmol) dropwise. After stirring for 15 min, 24 (5.40 g, 14.2 mmol) in methanol (20 mL) was cannulated 
into the flask and the reaction was stirred for 2 h before saturated NH4Cl solution (20 mL) was added. 
Methanol in the reaction mixture was removed under vacuum and diethyl ether (100 mL) was added. The 
mixture was stirred for another 10 min and the organic phase was separated. The aqueous phase was 
extracted with diethyl ether (2 × 30 mL) before the combined organic phase was dried over Na2SO4, filtered 
and concentrated. The residue was purified by chromatography (hexanes-EtOAc, 15:1, v/v) to give (S)-
methyl 5-(benzyloxy)-2-methylpentanoate (2.82 g, 11.9 mmol, 84%) as light yellow oil. 
  Rf 0.21 (hexanes-ethyl acetate, 20:1, v/v); [α]D25 +14.7 (c 0.82, CHCl3); IR (neat): 3084, 3056, 3028, 
2947, 2857, 1736, 1454, 1360, 1169, 1101, 736, 698 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.34-7.27 (m, 
5H), 4.49 (s, 2H), 3.66 (s, 3H), 3.46 (m, 2H), 2.46 (tq, J = 7, 7 Hz, 1H), 1.71 (m, 1H), 1.61 (m, 2H), 1.55 
(m, 1H), 1.16 (d, J = 7 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ 177.1, 138.6, 128.4, 127.6, 127.5, 72.9, 









(S)-Dimethyl (6-(benzyloxy)-3-methyl-2-oxohexyl)phosphonate (25) 
  To a -78 °C solution of dimethyl methylphosphonate (1.53 g, 12.4 mmol) in THF (50 mL) was added n-
butyllithium (2.5 M in hexanes, 5 mL, 12.5 mmol). The solution was stirred at -78 °C for 1 h before (S)-
methyl 5-(benzyloxy)-2-methylpentanoate (2.24 g, 9.5 mmol) in THF (20 mL) was cannulated into the 
reaction flask. The reaction mixture was stirred for one more hour before saturated NH4Cl solution (20 mL) 
was added. The mixture was warmed to room temperature and was stirred for 15 min. After removal of 
THF from the mixture on vacuum, the residue was extracted with diethyl ether (4 × 60 mL). The combined 
organic phase was dried over Na2SO4, filtered, and concentrated. Silica gel column chromatography 
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(hexanes-ethyl acetate, 1:1 to 1:4, v/v) of the residue gave product 25 (3.68 g, 11.2 mmol, 91%) as a clear 
colorless oil. 
  Rf 0.56 (hexanes-ethyl acetate, 1:5, v/v); [α]D25 +7.9 (c 0.58, CHCl3); IR (neat): 3083, 3058, 3022, 2953, 
2919, 2854, 1713, 1454, 1366, 1258, 1179, 1100, 1030, 876, 810, 740, 699 cm-1; 1H NMR (CDCl3, 500 
MHz): δ 7.35-7.27 (m, 5H), 4.48 (s, 2H), 3.77 (dd, J = 11.5, 2 Hz, 6H), 3.46 (m, 2H), 3.11 (d, J = 22.5 Hz, 
2H), 2.76 (tq, J = 7 Hz, 1H), 1.77 (m, 1H), 1.60 (m, 2H), 1.45 (m, 1H), 1.11 (d, J = 7 Hz, 3H); 13C NMR 
(CDCl3, 125 MHz): δ 205.5, 138.5, 128.4, 127.6, 127.6, 72.9, 70.0, 53.0, 46.9, 40.2, 39.1, 29.1, 27.2, 16.0; 








  To a 25 °C solution of 25 (1.89 g, 5.76 mmol) in CH3CN (20 mL) was added LiCl (0.285 g, 6.72 mmol) 
followed by diisopropylethylamine (1.2 mL, 6.72 mmol). The mixture was stirred for 15 min before 28 
(1.60 g, 5.12 mmol) in 10 mL CH3CN was cannulated into the reaction. The mixture was stirred for another 
16 h before saturated NH4Cl solution (5 mL) was added. CH3CN was removed from the mixture under 
vacuum and the residue was extracted with diethyl ether (4 × 60 mL). The combined organic phase was 
dried over Na2SO4, filtered, and concentrated. Silica gel column chromatography (hexanes-ethyl acetate, 
10:1, v/v) of the residue gave product 29 (2.55 g, 4.95 mmol, 97%) as a colorless oil. 
  Rf 0.68 (hexanes-ethyl acetate, 4:1, v/v); [α]D25 -0.8 (c 0.75, CHCl3); IR (neat): 3081, 3051, 3021, 2962, 
2909, 2855, 1693, 1667, 1632, 1620, 1538, 1454, 1360, 1099 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.36-
7.26 (m, 15H), 6.87 (dt, J = 15.5, 7.5 Hz, 1H), 6.20 (d, J = 15.5 Hz, 1H), 4.54 (d, J = 11.5 Hz, 1H), 4.74-
4.45 (m, 5H), 3.71 (m, 1H), 3.49 (dd, J = 9, 7 Hz, 1H), 3.44 (t, J = 6 Hz, 2H), 3.36 (dd, J = 9, 6 Hz, 1H), 
2.72 (tq, J = 7, 7 Hz, 1H), 2.50 (m, 1H), 2.43 (m, 1H), 1.99 (m, 1H), 1.74 (m, 1H), 1.58 (m, 2H), 1.45 (m, 
1H), 1.08 (d, J = 7 Hz, 3H), 0.98 (d, J = 7 Hz, 3H); 13C NMR (CDCl3, 125 MHz): δ 203.4, 143.9, 138.6, 
138.5, 130.7, 128.4, 128.3, 127.7, 127.7, 127.6, 127.6, 127.6, 127.5, 78.6, 73.1, 72.9, 72.5, 72.4, 70.2, 43.6, 









  A mixture of 29 (2.50 g, 4.86 mmol) and 20% Pd(OH)2 on carbon (0.30 g, 0.5 mmol) in absolute ethanol 
(50 mL) was stirred vigorously under 1 atm of H2 for 15 h. The mixture was filtered through Celite with 
ethyl acetate. The filtrate was concentrated and the residue was purified by silica gel column 
chromatography (hexanes−ethyl acetate, 5:1, v/v) to give 30 (1.03 g, 4.52 mmol, 93%) as a clear, colorless 
oil. 
  Rf 0.43 (hexanes-ethyl acetate, 4:1, v/v); [α]D25 +63.6 (c 0.68, CHCl3); IR (neat): 3404, 2930, 2877, 1452, 
1378, 1272, 1227, 1071, 1027, 990, 967, 947, 915, 865, 851, 800 cm-1; 1H NMR (CDCl3, 500 MHz): δ 3.82 
(ddd, J = 14.5, 5, 2.5 Hz, 1H), 3.75-3.56 (m, 4H), 2.82 (brt, J = 5 Hz, 1H), 2.06 (m, 1H), 1.90 (m, 1H), 1.74 
(m, 3H), 1.63 (m, 2H), 1.47 (m, 1H), 1.39 (td, J = 12.5, 4 Hz, 1H), 1.31 (m, 2H), 1.21 (td, J = 13.5, 4.5 Hz, 
1H), 0.99 (d, J = 7 Hz, 3H), 0.93 (d, J = 7 Hz, 3H); 13C NMR (CDCl3, 125 MHz): δ 98.4, 73.2, 66.4, 60.6, 









  To a solution of 30 (0.851 g, 3.73 mmol), triphenylphosphine (1.23 g, 4.68 mmol) and triethylamine (1.1 
mL, 7.80 mmol) in dichloromethane (20 mL) was added carbon tetrabromide (1.68 g, 5.07 mmol). The 
solution was stirred for 16 h before saturated NH4Cl solution (5 mL) and diethyl ether (30 mL) were added. 
The organic phase was separated and the aqueous phase was extracted with diethyl ether (3 × 30 mL). The 
combined organic phase was dried over Na2SO4, filtered, and concentrated. Silica gel column 
chromatography (hexanes-ethyl acetate, 30:1, v/v) of the residue gave product 8 (1.029 g, 3.54 mmol, 95%) 
as a colorless oil: 
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  Rf 0.50 (hexanes-ethyl acetate, 20:1, v/v); [α]D25 +67.2 (c 0.75, CHCl3); IR (neat): 2942, 2873, 1462, 
1378, 1270, 1239, 1211, 1194, 1171, 1107, 1067, 1027, 968, 948, 915, 866, 852, 738 cm-1; 1H NMR 
(CDCl3, 500 MHz): δ 3.68 (m, 2H), 3.58 (dd, J = 10, 5 Hz, 1H), 3.57 (m, 1H), 3.37 (dd, J = 10, 7 Hz, 1H), 
2.13 (m, 1H), 1.87 (m, 1H), 1.77 (m, 2H), 1.70 (m, 1H), 1.62 (m, 2H), 1.52 (m, 1H), 1.32-1.25 (m, 3H), 
1.15 (td, J = 13.5, 4.5 Hz, 1H), 1.11 (d, J = 6.5 Hz, 3H), 0.99 (d, J = 7.5 Hz, 3H); 13C NMR (CDCl3, 125 
MHz): δ 97.9, 70.4, 60.5, 40.8, 38.2, 35.9, 32.3, 27.6, 25.7, 19.8, 18.8, 14.4, 14.2; HRMS calcd for 






  To the solution of 31[4] (0.890 g, 1.82 mmol) in THF (15 mL) was added tetrabutylammonium fluoride (1 
M in THF, 2.2 mL, 2.2mmol). The mixture was stirred for 2 h before saturated NH4Cl solution (10 mL) and 
diethyl ether (20 mL) were added. The organic phase was separated and the aqueous phase was extracted 
with diethyl ether (20 mL) three more times. The organic extracts were combined and dried over Na2SO4. 
After filtration and evaporation of the solvent, the residue was purified through column chromatography to 
give 37 (0.681 g, 1.82 mmol, quant.) as a white solid: 
  Rf 0.10 (hexanes-ethyl acetate, 4:1, v/v); [α]D25 -31.1 (c 0.32, CHCl3); IR (neat): 3453, 3083, 3032, 2956, 
2873, 1643, 1453, 1354, 1130, 1100, 1043 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.33 (m, 5H), 5.86 (ddt, J 
= 17, 10, 6.5 Hz, 1H), 5.47 (t, J = 1.5 Hz, 1H), 5.13 (s, 1H), 5.05 (dq, J = 17, 1.5 Hz, 1H), 5.00 (dq, J = 10, 
1.5 Hz, 1H), 4.92 (d, J = 12 Hz, 1H), 4.78 (d, J = 12 Hz, 1H), 4.04 (dt, J = 9.5, 1.5 Hz, 1H), 3.95 (t, J = 
10.5 Hz, 1H), 3.50 (m, 3H), 3.22 (s, 3H), 2.08 (m, 2H), 1.96-1.76 (m, 5H), 1.59 (m, 2H); 13C NMR (CDCl3, 
125 MHz): δ 142.1, 138.7, 138.2, 128.3, 127.5, 127.5, 114.6, 113.0, 99.2, 80.3, 77.5, 76.7, 74.1, 69.5, 61.4, 







  To a 0 °C solution of alcohol 37 (120 mg, 0.32 mmol) in CH2Cl2 (5 mL) was added NaHCO3 (1.00 g, 11.9 
mmol) followed by Dess-Martin periodinane (0.50 g, 1.18 mmol). The reaction was stirred for 1 h before 
the addition of saturated NaS2O3 solution (1 mL) followed by diethyl ether (10 mL). The organic phase was 
separated and the aqueous phase was extracted with diethyl ether (3 × 5 mL). The combined organic phase 
was dried over Na2SO4, filtered and concentrated. The residue was passed through a pad of silica gel with a 
mixture of hexanes and ethyl acetate (3:1, v/v) and the filtrate was concentrated. The residue was used for 
next step without further purification. 
  To a -78 °C solution of 8 (374 mg, 1.28 mmol) in diethyl ether (8 mL) was added t-butyllithium (1.7 M in 
pentane, 1.4 mL, 2.4 mmol) dropwise. The reaction was stirred at -78 °C before warmed to room 
temperature. After stirred at room temperature for 30 min, the mixture was re-cooled to -78 °C before a 
solution of 7 (crude, 0.32 mmol theor) in diethyl ether (2 mL) was added via cannula. After 30 min, 
saturated NH4Cl solution (2 mL) was added before the mixture was warmed up to room temperature. The 
organic phase was separated and the aqueous phase was extracted with diethyl ether (4 × 3 mL). The 
combined organic phase was dried over Na2SO4, filtered, and concentrated. Silica gel column 
chromatography (hexanes-ethyl acetate, 8:1 to 2:1, v/v) of the residue gave 32 (39 mg, 0.0667 mmol) and 
32a (51 mg, 0.0873 mmol, 48% combined yield) as colorless oil.  Data for 32: 
  Rf 0.18 (hexanes-ethyl acetate, 4:1, v/v); [α]D20 +3.1 (c 0.54, CHCl3); IR (neat): 3425, 3068, 3028, 2942, 
2863, 1644, 1556, 1454, 1368, 1209, 1074, 1038 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.33 (m, 5H), 5.87 
(ddt, J = 17, 10, 6.5 Hz, 1H), 5.47 (t, J = 2 Hz, 1H), 5.07 (s, 1H), 5.06 (dd, J = 17, 1.5 Hz, 1H), 4.99 (dd, J 
= 10, 1.5 Hz, 1H), 4.90 (d, J = 12 Hz, 1H), 4.81 (d, J = 12 Hz, 1H), 3.94 (m, 3H), 3.67-3.55 (m, 3H), 3.44 
(m, 2H), 3.23 (s, 3H), 2.88 (brs, 1H), 2.19-2.04 (m, 3H), 1.95-1.55 (m, 13H), 1.47 (d, J = 12.5 Hz, 1H), 
1.32-1.08 (m, 5H), 1.00 (d, J = 7 Hz, 3H), 0.89 (d, J = 6.5 Hz, 3H); 13C NMR (CDCl3, 125 MHz): δ 142.4, 
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138.7, 138.2, 128.3, 127.5, 127.5, 114.6, 113.3, 99.2, 98.0, 85.1, 77.3, 73.7, 73.3, 70.2, 65.9, 60.4, 47.5, 
36.8, 35.9, 34.8, 34.5, 32.4, 27.9, 26.9, 25.7, 25.6, 20.0, 19.0, 15.0, 14.4; HRMS calcd for C35H52O7Na [M 






2-yl)butan-1-ol (32a).  Data for 32a: 
  Rf 0.34 (hexanes-ethyl acetate, 4:1, v/v); [α]D20 -4.1 (c 0.36, CHCl3); IR (neat): 3456, 3068, 3028, 2942, 
2870, 1643, 1454, 1358, 1213, 1094, 1044, 948, 914 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.44-7.30 (m, 
5H), 5.85 (ddt, J = 17, 10, 6.5 Hz, 1H), 5.52 (t, J = 2 Hz, 1H), 5.10 (t, J = 1.5 Hz, 1H), 5.05 (dd, J = 17, 1.5 
Hz, 1H), 4.98 (dd, J = 10, 1.5 Hz, 1H), 4.91 (d, J = 12 Hz, 1H), 4.80 (d, J = 12 Hz, 1H), 4.18 (d, J =10 Hz, 
1H), 4.12 (m, 1H), 4.01 (d, J = 8 Hz, 1H), 3.67-3.48 (m, 5H), 3.42 (t, J = 9.5 Hz, 1H), 3.22 (s, 3H), 2.90 
(brs, 1H), 2.11-2.04 (m, 3H), 1.95-1.45 (m, 14H), 1.40-1.12 (m, 5H), 0.99 (d, J = 7 Hz, 3H), 0.98 (d, J = 
7.5 Hz, 3H); 13C NMR (CDCl3, 125 MHz): δ 142.7, 139.0, 138.2, 128.3, 127.5,127.4, 114.5, 113.2, 99.1, 
98.6, 83.0, 78.0, 77.2, 73.9, 73.3, 71.0, 68.4, 60.7, 47.5, 36.2, 36.1, 34.8, 33.2, 32.4, 31.9, 27.9, 26.1, 25.8, 







  To a stirred 0 °C solution of 32 (39 mg, 0.0667 mmol) in THF (1.5 mL) was added 60% NaH (25 mg). 
The solution was stirred for 1 h before the addition of benzyl bromide (50 µL, 0.422 mmol) followed by 
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tetra-n-butylammonium iodide (5.0 mg, 0.0152 mmol). This mixture was allowed to warm to room 
temperature and stirred for 16 h. Diethyl ether (10 mL) and saturated aqueous NH4Cl (1 mL) were added, 
and the separated organic phase was washed with water (1 × 3 mL) and saturated aqueous NaCl solution (2 
× 3 mL). The aqueous phases were extracted with diethyl ether, and the combined organic phases were 
dried over Na2SO4, filtered, and concentrated. Silica gel column chromatography (hexanes-ethyl acetate, 
8:1, v/v) of the residue gave 33 (42 mg, 0.0623 mmol, 93%) as colorless oil: 
 Rf 0.63 (hexanes-ethyl acetate, 4:1, v/v); [α]D25 +11.4 (c 0.67, CHCl3); IR (neat): 3073, 3028, 2938, 2873, 
1598, 1454, 1350, 1094 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.33 (m, 10H), 5.86 (ddt, J = 17, 10, 6.5 Hz, 
1H), 5.47 (t, J = 1.5 Hz, 1H), 5.07 (dd, J = 18, 1.5 Hz, 1H), 5.05 (d, J = 1.5 Hz, 1H), 4.99 (dd, J = 10, 1.5 
Hz, 1H), 4.86 (d, J = 12 Hz, 1H), 4.78 (d, J = 12 Hz, 1H), 4.65 (d, J = 11 Hz, 1H), 4.53 (d, J = 11 Hz, 1H), 
4.36 (d, J = 7 Hz, 1H), 4.07 (d, J = 9.5 Hz, 1H), 3.92 (m, 1H), 3.69 (td, J = 10, 5 Hz, 1H), 3.62 (m, 1H), 
3.53 (dd, J = 11, 5, Hz, 1H), 3.44 (t, J = 10 Hz, 1H), 3.40 (m, 1H), 3.24 (s, 3H), 2.19-2.02 (m, 3H), 1.95-
1.55 (m, 13H), 1.47 (d, J = 12.5 Hz, 1H), 1.32-1.08 (m, 5H), 0.99 (d, J = 7 Hz, 3H), 0.86 (d, J = 6.5 Hz, 
3H); 13C NMR (CDCl3, 125 MHz): δ 144.1, 138.9, 138.8, 138.3, 128.3, 128.3, 127.8, 127.6, 127.5, 127.5, 
114.5, 112.0, 99.1, 97.9, 83.9, 77.8, 75.9, 73.6, 73.4, 72.3, 70.8, 60.4, 47.4, 36.0, 35.5, 34.9, 34.0, 32.4, 








  To a stirred solution of 33 (39 mg, 0.578 mmol) in THF (1.5 mL) and H2O (0.5 mL) was added sodium 
periodate (40 mg, 0.173 mmol), pyridine (1 µL) and OsO4 (50 µL, 4% in water). The mixture was stirred 
for 2 h before 2 mL of 20% Na2S2O3 solution was added. The mixture was stirred for another 15 min and 
10 mL diethyl ether was added. The organic phase was separated and the aqueous phase was extracted with 
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diethyl ether (3 × 5 mL). The combined organic phase was dried over Na2SO4 filtered, and concentrated. 
Silica gel column chromatography (hexanes-ethyl acetate, 4:1, v/v) of the residue gave 34 (30 mg, 0.0443 
mmol, 77%) as a colorless oil. 
  Rf 0.18 (hexanes-ethyl acetate, 4:1, v/v); [α]D25 +10.8 (c 0.50, CHCl3); IR (neat): 3080, 3037, 3027, 2937, 
2861, 2711, 1728, 1454, 1386, 1363, 1273, 1213, 1092, 1040 cm-1; 1H NMR (CDCl3, 500 MHz): δ 9.80 (s, 
1H), 7.33 (m, 10H), 5.43 (t, J = 1.5 Hz, 1H), 5.05 (s, 1H), 4.81 (d, J = 12 Hz, 1H), 4.74 (d, J = 12 Hz, 1H), 
4.63 (d, J = 11 Hz, 1H), 4.53 (d, J = 11 Hz, 1H), 4.36 (d, J = 7 Hz, 1H), 4.07 (d, J = 9.5 Hz, 1H), 3.91 (m, 
1H), 3.70-3.60 (m, 2H), 3.53 (dd, J = 11, 5 Hz, 1H), 3.41 (t, J = 9.5 Hz, 1H), 3.40 (m, 1H), 3.22 (s, 3H), 
2.48 (dd, J = 8, 7 Hz, 1H), 2.14 (tt, J = 12, 5 Hz,1H), 2.06 (m, 1H), 1.93 (m, 1H), 1.86-1.51 (m, 13H), 1.47 
(d, J = 12.5 Hz, 1H), 1.31-1.09 (m, 5H), 0.99 (d, J = 7.5 Hz, 1H), 0.88 (d, J = 7 Hz, 1H); 13C NMR (CDCl3, 
125 MHz): δ 201.3, 144.0, 138.8, 138.7, 128.3, 127.8, 127.6, 127.5, 112.0, 98.7, 97.9, 83.6, 77.8, 76.3, 
73.7, 73.4, 72.3, 70.6, 60.4, 47.5, 38.7, 36.0, 35.4, 34.0, 32.3, 32.2, 27.7, 26.7, 25.8, 25.5, 20.0, 19.0, 15.5, 







  To a stirred −78 °C solution of dimethyl methylphosphonate (40 µL, 0.37 mmol) in THF (1.5 mL) under 
argon was added tert-butyllithium (180 µL of a 1.7 M solution in pentane, 280 µmol) dropwise. The 
solution was stirred for 45 min before a solution of 34 (26 mg, 39 µmol) in THF (1 mL) was added slowly 
via cannula. The resultant pale yellow solution was stirred for an additional 45 min, at which time TLC 
showed no remaining 34. Saturated aqueous NaCl (1 mL) was added, and the mixture was allowed to warm 
to room temperature. THF was removed by rotary evaporation and the aqueous residue was extracted with 
diethyl ether (15 mL). The separated organic phase was washed with H2O (2 × 3 mL) and saturated 
aqueous NaCl (2 × 3 mL). The combined aqueous phases were extracted with ethyl acetate, and the 
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combined organic phases were dried over Na2SO4, filtered, and concentrated. The residue was filtered 
through silica gel with hexanes−ethyl acetate−triethylamine (1:5:0.3, v/v) and the filtrate concentrated to 
yield crude β-hydroxy phosphonate as oil, which was used without further purification. 
  To a stirred room temperature solution of β-hydroxy phosphonate (39 µmol theor.) in CH2Cl2 (1 mL) was 
added NaHCO3 (120 mg, 1.4 mmol) and Dess−Martin periodinane reagent (60 mg, 0.14 mmol). The 
resultant mixture was stirred for 45 min, at which time TLC showed no remaining β-hydroxy phosphonate. 
Diethyl ether (15 mL), saturated aqueous NaHCO3 (1 mL), and 10% aqueous Na2S2O3 (1 mL) were added, 
and the mixture was stirred vigorously until the organic layer became clear. The separated organic phase 
was washed with H2O (2 × 3 mL) and saturated aqueous NaCl (2 × 3 mL). The aqueous phases were 
extracted with diethyl ether, and the combined organic phases were dried over Na2SO4, filtered, and 
concentrated. The residue was purified by silica gel column chromatography (hexanes−ethyl acetate, 
1:2−1:5, v/v) to give 6 (21.4 mg, 27 µmol, 70% from 34) as a pale oil: 
  Rf 0.36 (hexanes-ethyl acetate, 1:5, v/v); [α]D25 +12.8 (c 0.33, CHCl3); IR (neat): 3080, 3060, 2925, 2850, 
1713, 1591, 1454, 1123, 1089, 1029 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.33 (m, 10H), 5.43 (s, 1H), 5.04 
(s, 1H), 4.83 (d, J = 12.5 Hz, 1H), 4.75 (d, J = 12.5 Hz, 1H), 4.64 (d, J = 12 Hz, 1H), 4.52 (d, J = 12 Hz, 
1H), 4.35 (d, J = 7 Hz, 1H), 4.06 (d, J = 9.5 Hz, 1H), 3.92 (m, 1H), 3.78 (d, JP-H = 11.5 Hz, 1H), 3.70-3.59 
(m, 2H), 3.53 (m, 1H), 3.41 (m, 2H), 3.22 (s, 3H), 3.11 (d, JP-H = 22.5 Hz, 6H), 2.65 (t, J = 8 Hz, 2H), 2.17-
2.05 (m, 2H), 1.77-1.90 (m, 7H), 1.47-1.68 (m, 8H), 1.35-1.45 (m, 3H), 0.99 (d, J = 6.5 Hz, 3H), 0.87 (d, J 
= 7.0 Hz, 3H); 13C NMR (CDCl3, 125 MHz): δ 201.1, 144.0, 138.8, 138.7, 128.3, 127.9, 127.6, 127.5, 
127.5, 112.0, 98.7, 97.9, 83.8, 77.8, 76.1, 73.6, 73.4, 72.3, 70.6, 60.4, 53.1, 53.1, 47.5, 42.1, 41.0, 38.7, 
36.0, 35.5, 34.0, 32.4, 32.2, 29.7, 29.0, 26.8, 25.8, 25.5, 20.0, 19.9, 15.4, 14.4; HRMS calcd for 












  To a stirred solution of 6 (20 mg, 25 µmol) in CH3CN (0.6 mL) was added LiCl (5 mg, 0.12 mmol) 
followed by diisopropylethylamine (7 µL, 0.035 mmol). After stirring for 10 min, a solution of 5 (10.5 mg, 
23 µmol) in CH3CN (0.8 mL) was added. The resulting mixture became turbid after 10 min and was stirred 
for an additional 20 h. The mixture was diluted with diethyl ether (5 mL), washed with H2O and saturated 
aqueous NaCl (0.5 mL ea), dried over Na2SO4, filtered, and concentrated. Silica gel column 
chromatography (hexanes−ethyl acetate, 5:1, v/v) of the residue gave 4 (25.2 mg, 22 µmol, 93%) as a clear, 
colorless oil: 
  Rf 0.24 (hexanes-ethyl acetate, 4:1, v/v); [α]D20 +10.5 (c 0.29, CHCl3); IR (neat): 3082, 3064, 3025, 2931, 
2844, 1674, 1629, 1454, 1378, 1239, 1208, 1090, 1026, 983, 912, 855, 813, 734, 698 cm-1; 1H NMR 
(CDCl3, 500 MHz): δ 7.37-7.26 (m, 15H), 7.08 (dd, J = 16, 7.5 Hz, 1H), 6.19 (d, J = 16 Hz, 1H), 5.43 (s, 
1H), 5.16 (s, 1H), 5.04 (s, 1H), 4.85 (d, J = 12.5 Hz, 1H), 4.76 (d, J = 12 Hz, 1H), 4.64 (d, J = 11 Hz, 1H), 
4.59 (d, J = 12.5 Hz), 4.52 (d, J = 11 Hz, 1H), 4.46 (d, J = 12.5 Hz, 1H), 4.35 (d, J = 7 Hz, 1H), 4.05 (d, J = 
10 Hz, 1H), 3.91 (m, 1H), 3.80 (d, J = 8.5 Hz), 3.80 (m, 1H), 3.66 (d, J = 8.5 Hz, 1H), 3.71- 3.59 (m, 3H), 
3.54 (m, 1H), 3.40 (t, J = 10 Hz, 1H), 3.39 (m, 1H), 3.24 (dd, J = 12, 4 Hz, 1H), 3.19 (s, 3H), 2.56 (m, 3H), 
2.14 (m, 2H), 2.03 (t, J = 11 Hz, 1H), 1.94 (td, J = 13, 3 Hz, 1H), 1.82-1.76 (m, 9H), 1.73 (s, 3H), 1.72-
1.48 (m, 11H), 1.39 (s, 3H), 1.31 (s, 3H), 1.26 (s, 3H), 1.16 (d, J = 7 Hz, 3H), 0.99 (d, J = 7 Hz, 1H), 0.86 
(d, J = 7 Hz, 1H); 13C NMR (CDCl3, 125MHz) δ 199.2, 149.2, 144.0, 138.9, 138.8, 138.7, 136.5, 130.1, 
128.3, 128.2, 127.9, 127.7, 127.6, 127.5, 127.5, 127.4, 123.1, 112.1, 108.3, 98.9, 97.9, 96.0, 83.9, 80.3, 
79.0, 78.6, 78.2, 77.6, 77.4, 75.8, 75.1, 73.7, 73.4, 72.3, 71.3, 70.6, 66.5, 60.4, 47.5, 46.1, 41.3, 36.0, 35.5, 
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34.5, 34.0, 33.4, 32.4, 32.3, 32.3, 29.3, 27.5, 27.0, 26.8, 25.8, 25.5, 24.4, 24.3, 22.9, 20.0, 19.0, 15.5, 15.4, 








  To a stirred solution of (S)-2-methyl-CBS-oxazaborolidine (200 µL of a 1.0 M solution in toluene, 0.20 
mmol) in THF (0.6 mL) at 0 °C and under N2 was added borane-tetrahydrofuran complex (140 µL of a 1 M 
solution in THF, 140 µmol) followed by a solution of 4 (12.0 mg, 10.6 µmol) in THF (0.35 mL). After 7 
min, H2O (200 µL) was added and the mixture was allowed to warm to room temperature. Diethyl ether (2 
mL) was added and the mixture was washed with 5% aqueous HCl. The aqueous phase was extracted with 
diethyl ether (2 × 0.5 mL), and the combined organic phases were washed with H2O and saturated aqueous 
NaCl (0.5 mL ea), dried over Na2SO4, filtered, and concentrated. The crude allylic alcohol (Rf 0.40; 
hexanes−ethyl aceatate, 2:1, v/v) was filtered through silica gel with ethyl acetate, the filtrate was 
concentrated and then diluted with a mixture of THF (0.65 mL), acetic acid (0.50 mL) and H2O (0.26 mL) 
in a 10 mL vial. The vial was then capped and the reaction was heated at 55o C for 40 h before being cooled 
to room temperature. The solvent was removed by vacuum and the residue was purified through column 
chromatography (hexanes-ethyl acetate, 4:1 to 2:1) to give 35 (9.0 mg, 8.5 µmol, 80%) as white solid. 
  Rf 0.31 (hexanes-ethyl acetate, 2:1, v/v); [α]D20 +30.5 (c 0.20, CHCl3); IR (neat): 3399, 2920, 2852, 1644 
1378, 1180, 1078, 1027, 964, 734, cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.33-7.25 (m, 15H), 5.83 (dd, J = 
15.5, 7.5 Hz, 1H), 5.60 (dd, J = 15.5, 7 Hz, 1H), 5.39 (t, J = 1.5 Hz, 1H), 5.15 (s, 1H), 5.02 (s, 1H), 4.81 (d, 
J = 12.5 Hz, 1H), 4.76 (d, J = 12.5 Hz, 1H), 4.66 (d, J = 11.5 Hz, 1H), 4.61 (d, J = 12.5 Hz, 1H), 4.58 (m, 
1H), 4.51 (d, J = 11.5 Hz, 1H), 4.47 (d, J = 12.5 Hz, 1H), 4.30 (d, J = 7 Hz, 1H), 4.11 (brt, J = 11 Hz, 1H), 
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4.01 (d, J = 9.5 Hz, 1H), 3.90 (m, 1H), 3.69-3.58 (m, 4H), 3.53 (m, 2H), 3.46-3.35 (m, 3H), 3.24 (dd, J = 
12, 4 Hz, 1H), 2.65 (brs, 1H), 2.43 (tq, J = 7.5, 7.5 Hz, 1H), 2.22-1.93 (m, 6H), 1.88−1.77 (m, 10H), 1.73 
(s, 3H), 1.69−1.30 (m, 14H), 1.12 (s, 3H), 1.04 (d, J = 7.0 Hz, 3H), 0.99 (d, J = 7.5 Hz, 3H), 0.82 (d, J = 
7.0 Hz, 3H); 13C NMR (CDCl3, 125MHz) δ 143.9, 138.8, 138.7, 137.9, 130.9, 128.3, 128.3, 128.2, 127.9, 
127.8, 127.6, 127.5, 127.5, 122.5, 112.1, 105.6, 97.9, 96.4, 84.2, 79.0, 78.6, 77.6, 75.3, 73.4, 73.3, 72.7, 
72.4, 72.2, 71.4, 70.6, 69.1, 67.4, 60.4, 43.9, 40.9, 37.2, 36.0, 35.7, 34.0, 33.4, 33.0, 32.5, 32.3, 30.7, 27.0, 
26.7, 25.8, 25.2, 23.9, 23.0, 20.0, 19.0, 15.6, 15.0, 14.4; HRMS calcd for C69H94O13Na [M + Na]+: 







dioxaspiro[5.5]undec-10-en-2-yl)-2-hydroxy-2-methylpropanoic acid (36) 
  To a stirred solution of 35 (3.9 mg, 3.7 µmol), DMSO (0.05 mL) and diisopropylethylamine (0.10 mL) in 
CH2Cl2 (0.10 mL) was added sulfur trioxide pyridine complex (5.0 mg, 31.4 µmol). The mixture was 
stirred for 2 h before saturated NH4Cl solution (1 mL) and diethyl ether (2 mL) was added. After stirring 
for another 15 min, the organic phase was separated and the aqueous phase was extracted with diethyl ether 
(4 × 1 mL). The combined organic phase was dried over Na2SO4, filtered, and concentrated. The crude 
product was then dissolved in a mixture of t-butanol (0.25 mL) and water (0.05 mL) before NaH2PO4·2H2O 
(7 mg, 44.9 µmol), 2-methyl-2-butene (0.2 mL) and NaClO2 (4 mg, 44.2 µmol) were added in sequence. 
The mixture was stirred for 1 h before saturated Na2S2O3 solution (1 mL) was added. The mixture was 
stirred for another 20 min before the solution was acidified to pH = 2 with 1 M HCl. The mixuture was then 
extracted with diethyl ether (6 × 1 mL) and the combined organic extract was dried over Na2SO4, filtered, 
and concentrated. Silica gel column chromatography (dichloromethane−methanol, 20:1, v/v) of the residue 
gave 36 (3.5 mg, 3.3 µmol, 89%) as a clear, colorless oil: 
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  Rf 0.48 (dichloromethane-methanol, 19:1, v/v); [α]D25 +42.9 (c 0.22, CHCl3); IR (neat): 3067, 3020, 2925, 
2851, 1730, 1713, 1462, 1378, 1075, 1028, 965 cm-1; 1H NMR (CDCl3, 500 MHz): δ 5.74 (dd, J = 15, 8 
Hz, 1H), 5.61 (dd, J = 15.5, 7.5 Hz, 1H), 5.43 (s, 1H), 5.13 (s, 1H), 5.04 (s, 1H), 4.88 (d, J = 12.5 Hz, 1H), 
4.78 (d, J = 12.5 Hz, 1H), 4.66 (d, J = 11.5 Hz, 1H), 4.62 (m, 1H), 4.60 (d, J = 12.5 Hz, 1H), 4.51 (d, J = 11 
Hz, 1H), 4.47 (d, J = 12.5 Hz, 1H), 4.32 (d, J = 7.5 Hz, 1H), 4.05 (m, 1H), 3.90 (m, 1H), 3.69-3.52 (m, 5H), 
3.37 (ddd, J = 11.5, 5, 2 Hz, 1H), 3.25 (dd, J = 12, 4 Hz, 1H), 2.42 (tq, J = 7.5, 7.5 Hz, 1H), 2.22-1.93 (m, 
6H), 1.88−1.77 (m, 10H), 1.72 (s, 3H), 1.69−1.30 (m, 14H), 1.35 (s, 3H), 1.05 (d, J = 7.0 Hz, 3H), 0.99 (d, 
J = 7.5 Hz, 3H), 0.82 (d, J = 7.0 Hz, 3H); 13C NMR (CDCl3, 125MHz) δ 176.4, 143.8, 139.0, 138.8, 138.7, 
135.0, 131.3, 128.4, 128.3, 128.0, 127.9, 127.8, 127.7, 127.6, 122.2, 112.2, 105.8, 98.0, 96.6, 84.3, 79.3, 
78.5, 77.9, 75.7, 75.6, 74.5, 73.5, 73.4, 72.5, 71.6, 71.3, 70.8, 68.4, 60.5, 43.8, 41.6, 37.4, 36.2, 35.8, 34.1, 
32.9, 32.8, 32.5, 32.3, 32.1, 30.4, 29.5, 29.4, 27.5, 27.1, 26.9, 26.7, 25.9, 23.7, 23.2, 22.9, 22.8, 20.1, 19.2, 






dioxaspiro[5.5]undec-10-en-2-yl)-2-methylpropanoic acid (3) 
  To a stirred −78 °C solution of 36 (2.1 mg, 1.9 µmol) in THF (0.2 mL) under argon was added a solution 
of lithium di-tert-butylbiphenylide (0.5 mL of 0.13 M solution in THF, 0.06 mmol). After stirring for 30 
min, H2O (0.2 mL) was added to the deep blue-green solution and the resulting colorless mixture was 
allowed to warm to room temperature. The THF was removed under a stream of argon, and the residue was 
diluted with H2O (0.2 mL) and washed with hexanes (3 × 1 mL). The aqueous phase was cooled to 0 °C 
and was acidified to pH 2 with 0.5 M aqueous HCl, and extracted with diethyl ether (4 × 1 mL). The 
combined ether extracts were dried over Na2SO4, filtered, and concentrated. The residue was purified by 
silica gel column chromatography (dichloromethane-methanol, 18:1, v/v) to give 3 (1.0 mg, 1.3 µmol, 
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69%) as a colorless solid. This material matched the data reported for the natural product by NMR 
spectroscopy, sign of optical rotation, hplc retention time, and HRMS.  
 Rf 0.24 (dichloromethane-methanol, 19:1, v/v); [α]D25 +12.0 (c 0.075, CHCl3); 1H NMR (CD3OD, 500 
MHz): δ 5.84 (dd, J = 15.5, 8.5 Hz, 1H), 5.52 (dd, J = 15.5, 8 Hz, 1H), 5.36 (s, 1H), 5.29 (s, 1H), 4.62 (q, J 
= 7 Hz, 1H), 4.10 (m, 1H), 4.07 (m, 1H), 3.97 (d, J = 9 Hz, 1H), 3.75-3.62 (m, 3H), 3.51 (dd, J = 11, 5 Hz, 
1H), 3.45-3.35 (m, 3H), 2.34 (q, J = 1.75 Hz, 1H), 2.20-2.15 (m, 2H), 2.00-1.95 (m, 3H), 1.90-1.16 (m, 
23H), 1.75 (s, 3H), 1.34 (s, 3H), 1.07 (d, J = 7 Hz, 3H), 0.99 (d, J = 7 Hz, 3H), 0.95 (d, J = 7 Hz, 3H); 13C 
NMR (CDCl3, 125MHz) δ 147.5, 140.0, 137.5, 132.4, 123.1, 112.1, 107.1, 99.3, 97.7, 86.4, 80.5, 78.1, 
76.3, 75.0, 73.1, 72.2, 72.0, 71.4, 69.5, 67.1, 61.4, 45.6, 43.4, 38.6, 38.1, 37.4, 35.3, 34.1, 34.1, 33.4, 31.6, 
28.6, 27.7, 27.6, 26.7, 23.1, 21.0, 20.1, 16.7, 14.7, 14.4; HRMS calcd for C44H68O13Na [M + Na]+: 
827.4558; found: 827.4527. 
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 To a mixture of 17 (1.542 g, 4.10 mmol), tert-butanol (20 mL) and water (20 mL) at 0 °C was added AD-
mix-α (5.74 g). The mixture was stirred vigorously for 24 h then sodium sulfite (6.2 g) was added. The 
mixture was stirred at 25 °C for 1 h before diethyl ether (20 mL) was added. The organic phase was 
separated and the aqueous phase was extracted with diethyl ether (4 × 20 mL).  The combined organic 
phase was dried over Na2SO4, filtered and concentrated. The residue was purified through column 
chromatography (hexanes-ethyl acetate, 4:1 to 2:1 to 1:1, v/v) to give 18 (0.156 g, 0.381 mmol, 9.3%) and 
18a (1.391g, 3.39 mmol, 83%) as colorless oils.  Data for 18a: 
Rf 0.30 (hexanes-ethyl acetate, 2:1, v/v); [α]D25 = +11.8 (c 2.40, CDCl3); IR (neat): 3416, 2929, 2858, 1648, 
1456, 1396, 1252, 1170, 836 cm-1; 1H NMR (CDCl3, 500 MHz) δ 7.33 (m, 5H), 4.74 (d, J = 12 Hz, 2H), 
4.63 (m, 2H), 3.86 (t, J = 11 Hz, 1H), 3.74 (s, 1H), 3.42 (dd, J = 11, 5 Hz, 1H), 3.32 (dd, J = 11, 8 Hz), 3.16 
(m, 1H), 2.31 (dd, J = 8, 5.5 Hz), 2.06 (m, 1H), 1.98 (dd, J = 14.5, 9.5 Hz, 1H), 1.60-1.41 (m, 4H), 1.22 (s, 
3H), 0.95 (s, 9H), 0.17(m, 6H). 13C NMR (CDCl3, 125MHz) δ 138.6, 128.3, 127.3, 99.4, 78.0, 73.5, 72.6, 
72.3, 70.9, 42.1, 31.5, 28.8, 25.6, 23.9, 17.9, -4.5, -4.9. HRMS calcd for C22H38O5SiNa [M + Na]+: 










  To a solution of 18a (1.560g, 3.80 mmol) in CH2Cl2 (20 mL) was added 2,2-dimethoxypropane (3.0 mL, 
24.4 mmol) followed by pyridinium p-toluenesulfonate (37 mg, 0.14 mmol). The reaction mixture was 
stirred for 2.5 h then triethylamine (0.5 mL) was added. The solvent was evaporated and the residue was 
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filtered through a pad of silica gel with hexanes-ethyl acetate (4:1, v/v). The filtrate was concentrated and 
the residue was dissolved in THF (20 mL).  A solution of tetra-n-butylammonium fluoride (1.0 M in THF, 
3.90 mL, 3.90 mmol) was added dropwise over 1 h. The mixture was stirred for another 0.5 h and saturated 
ammonium chloride solution (5 mL) was added. THF was removed from the mixture and diethyl ether (20 
mL) was added. The mixture was stirred for 10 min before the organic phase was separated. The aqueous 
phase was extracted with diethyl ether (3 × 25 mL). The combined organic phase was dried over Na2SO4, 
filtered and concentrated. The residue was filtered through a pad of silica gel with hexanes-ethyl acetate 
(2:1, v/v) and the filtrate was concentrated. The residue was dissolved in CH2Cl2 (20 mL) and NaHCO3 
(1.03 g, 12.3 mmol), iodobenzene diacetate (1.69 g, 5.25 mmol) and 2,2,6,6-tetramethylpiperidine-1-oxyl 
(54 mg, 0.35 mmol) were added. The mixture was stirred for 12 h before saturated Na2S2O3 solution (3.0 
mL) was added. Diethyl ether (30 mL) was added and the organic phase was separated. The aqueous phase 
was extracted with diethyl ether (3 × 25 mL). The combined organic phase was washed with brine, dried 
over Na2SO4, filtered, concentrated and purified by flash chromatography (hexanes: ethyl acetate, 4:1, v/v) 
to give compound 10a (0.956 g, 2.86 mmol, 75%, three steps) as a colorless oil. 
 Rf 0.34 (hexanes-ethyl acetate, 4:1, v/v); [α]D25 = +35.0 (c 0.34, CDCl3); IR (neat): 3058, 3027, 2928, 
2930, 2868, 1745, 1454, 1379, 1246, 1209, 1118, 1058, 807, 738, 700 cm-1; 1H NMR (CDCl3, 500 MHz): δ 
7.36 (m, 5H), 4.86 (d, J = 12 Hz, 1H), 4.82 (m, 1H), 4.06 (d, J = 8.5 Hz, 1H), 3.97 (t, J = 6 Hz, 1H), 3.72 
(d, J =8.5 Hz, 1H), 2.17-1.94 (m, 4H), 1.82 (dd, J = 15, 3.5 Hz, 1H), 1.69 (m, 1H), 1.41 (s, 3H), 1.33 (s, 
3H), 1.32 (s, 3H). 13C NMR (CDCl3, 125MHz) δ 170.6, 137.3, 128.5, 128.1, 128.0, 109.2, 79.7, 76.5, 73.8, 
















  To a stirred -78 °C solution of 20 (2.154 g, 5.94 mmol) in THF (20 mL) was added n-butyllithium (1.0 
mL of a 2.5 M solution in hexanes, 2.5 mmol). After the mixture was stirred for 40 min, a solution of 10a 
(0.903 g, 2.70 mmol) in THF (5 mL) was added via cannula. After 1 h, saturated aqueous NH4Cl solution 
(15 mL) was added and the mixture was warmed to room temperature. The mixture was extracted with 
diethyl ether (3×50 mL) and the combined organic extracts were washed with water and saturated aqueous 
NaCl. The combined organic fraction was dried over Na2SO4, filtered and concentrated. The residue was 
chromatographed on silica gel (hexanes-ethyl acetate, 5:1, v/v) to give 21a (1.50 g, 2.23 mmol, 83%) as 
colorless oil. 
 To a solution of 21a (1.27 g, 1.90 mmol) in CH2Cl2 (16 mL) at 0 °C was added imidazole (0.260 g, 3.80 
mmol), followed by chlorotrimethylsilane (0.36 mL, 2.85 mmol) and 4-dimethylaminopyridine (23 mg, 
0.190 mmol). After stirring for 50 min, saturated aqueous NH4Cl solution (10 mL) was added. The mixture 
was extracted with diethyl ether (3 × 35 mL) and the combined organic phases were washed with water and 
saturated aqueous NaCl (16 mL), dried over Na2SO4, filtered, and concentrated. The residue of crude TMS-
protected 21a was directly used for next step without further purification. 
  To a -78 °C suspension of CuI (1.49 g, 7.80 mmol) in diethyl ether (6 mL) under argon was added 
methyllithium (9.7 mL of a 1.6 M solution in diethyl ether, 15.6 mmol). The mixture was allowed to warm 
slowly to -30 °C until a clear and colorless solution formed. The solution was cooled to -78 °C, and the 
solution of crude TMS-protected 21a in diethyl ether (5 mL) was added via cannula. After 1.0 h, saturated 
aqueous NH4Cl (10 mL) was added and the mixture was warmed to room temperature and stir until the 
aqueous phase became bright blue. The solution was extracted with diethyl ether (3 × 30 mL) and the 
combined organic phases were washed with water and saturated aqueous NaCl (15 mL), dried over 
Na2SO4, filtered, and concentrated to give a crude enone product.   This was dissolved in a mixture of 
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dichloromethane (20 mL), methanol (8 mL), and pyridinium p-toluenesulfonate (16 mg, 0.059 mmol). 
After the solution was stirred at 25 °C for 2 h, triethylamine (0.50 mL) was added. After the mixture was 
stirred for 10 min, the solvent was removed and the residue was purified via chromatography (hexanes-
ethyl acetate, 8:1 to 6:1, v/v) to give 23a (0.371 g, 0.64 mmol, 34% based on 21a) as colorless oil. 
  Rf 0.43 (hexanes-ethyl acetate, 4:1, v/v); [α]D25 = +24.2 (c 1.1, CDCl3); IR (neat): 3058, 3026, 2930, 2861, 
1611, 1512, 1247, 1095 cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.32-7.24 (m, 7H), 6.86 (m, 2H), 5.18 (s, 
1H), 4.61 (d, J = 12.5 Hz, 1H), 4.49 (d, J = 12.5 Hz, 1H), 4.44 (d, J = 2 Hz, 2H), 3.80-3.67 (m, 6H), 3.64 
(d, J = 8 Hz, 1H), 3.34 (t, J = 8.5 Hz, 1H), 3.26 (dd, J = 12, 4.5 Hz, 1H), 2.11 (m, 1H), 2.04 (dd, J = 16.5, 
11.5 Hz, 1H), 1.92 (qd, J = 12.5, 4 Hz, 1H), 1.83-1.76 (m, 3H), 1.73 (s, 3H), 1.62 (dd, J = 13, 6 Hz, 2H), 
1.37 (s, 3H), 1.33 (s, 3H), 1.27 (s, 3H), 1.03 (d, J = 7 Hz, 3H); 13C NMR (CDCl3, 125MHz) δ 159.1, 139.0, 
137.2, 130.9, 129.2, 128.1, 127.7, 127.4, 123.0, 113.7, 108.8, 96.2, 80.5, 78.7, 73.6, 72.7, 72.4, 71.3, 69.7, 
66.4, 55.3, 45.9, 38.4, 32.8, 32.7, 27.3, 27.2, 26.3, 24.4, 23.0, 13.8; HRMS calcd for C35H48O7Na [M + 










 To a mixture of 23a (30 mg, 51 µmol), CH2Cl2 (5.0 mL), an aqueous NaH2PO4 buffer (pH = 7, 1.0 mL), 
and tert-butyl alcohol (0.30 mL) was added 2,3-dichloro-5,6-dicyanobenzoquinone (70 mg, 0.31 mmol). 
The reaction flask was placed in an aqueous bath and sonicated for 5 min. The mixture was diluted with 
diethyl ether (8 mL) and washed with saturated aqueous NaHCO3 solution (2 mL). The aqueous phase was 
extracted with diethyl ether (3 × 2 mL) and the combined organic phases were washed with saturated 
aqueous NaCl (1.5 mL), dried over Na2SO4, filtered, and concentrated. The residue was purified by silica 
gel column chromatography (hexanes−ethyl acetate, 5:1 to 3:2, v/v) to give a colorless oil which was then 
dissolved in CH2Cl2 (3.0 mL).  NaHCO3 (150 mg, 1.8 mmol) followed by the Dess−Martin periodinane  
(80 mg, 0.19 mmol) were added to the solution. The mixture was stirred for 30 min before diethyl ether 
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(4.0 mL) and 10% aqueous Na2S2O3 and saturated aqueous NaHCO3 (1.0 mL ea.) were added. The mixture 
was stirred until the organic phase became clear and colorless. The separated aqueous phase was extracted 
with diethyl ether (3 × 2 mL), and the combined organic fractions were washed with saturated aqueous 
NaCl (1 mL), dried over Na2SO4, filtered, and concentrated. Silica gel column chromatography 
(hexanes−ethyl acetate, 5:1, v/v) of the residue gave 5a (17 mg, 35 µmol, 69%, two steps) as a white 
crystalline solid. 
 Rf 0.70 (hexanes-ethyl acetate, 4:1, v/v); [α]D25 = +16.1 (c 0.18, CDCl3); IR (neat): 3066, 3035, 2924, 
2852, 1727, 1604, 1454, 1378, 1245, 1209, 1089, 1051 cm-1; 1H NMR (CDCl3, 500 MHz): δ 9.92 (d, J = 
2.5 Hz, 1H), 7.32-7.24 (m, 5H), 5.20 (s, 1H), 4.61 (d, J = 12 Hz, 1H), 4.47 (d, J = 12 Hz, 1H), 4.10 (m, 
1H), 3.89 (d, J = 8.5 Hz, 1H), 3.80 (m, 1H), 3.71 (d, J = 8.5 Hz, 1H), 3.26 (dd, J = 11.5, 4.5 Hz, 1H), 2.71 
(m, 1H), 2.09 (dd, J = 14, 11.5 Hz, 1H), 1.90-1.71 (m, 4H), 1.71 (s, 3H), 1.36 (s, 3H), 1.33 (s, 3H), 1.29 (s, 
3H), 1.11 (d, J = 7 Hz, 3H); 13C NMR (CDCl3, 125MHz) δ 204.3, 138.8, 136.4, 128.2, 127.8, 127.5, 123.3, 
108.9, 96.3, 80.3, 78.5, 73.6, 71.4, 69.2, 66.7, 50.5, 46.0, 33.1, 32.7, 27.2, 27.1, 26.4, 24.3, 23.0, 10.4; 






















  To a stirred solution of 6 (15 mg, 18 µmol) in CH3CN (0.6 mL) was added LiCl (5 mg, 0.12 mmol) 
followed by diisopropylethylamine (7 µL, 0.035 mmol). After stirring for 10 min, a solution of 5 (8.6 mg, 
18 µmol) in CH3CN (0.8 mL) was added. The resulting mixture became turbid after 10 min and was stirred 
for an additional 20 h. The mixture was diluted with diethyl ether (5 mL), washed with H2O and saturated 
aqueous NaCl (0.5 mL ea), dried over Na2SO4, filtered, and concentrated. Silica gel column 
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chromatography (hexanes−ethyl acetate, 5:1, v/v) of the residue gave 4a (18.2 mg, 16 µmol, 89%) as a 
clear, colorless oil: 
  Rf 0.18 (hexanes-ethyl acetate, 4:1, v/v); [α]D20 = +13.3 (c 0.33, CDCl3); IR (neat): 3082, 3060, 3025, 
2931, 2852, 1674, 1629, 1454, 1378, 1239, 1208, 1090, 1026, 983, 912, 856, 734, 698 cm-1; 1H NMR 
(CDCl3, 500 MHz): δ 7.34-7.24 (m, 15H), 7.07 (dd, J = 16, 7.5 Hz, 1H), 6.21 (d, J = 16 Hz, 1H), 5.43 (s, 
1H), 5.20 (s, 1H), 5.04 (s, 1H), 4.86 (d, J = 12.5 Hz, 1H), 4.76 (d, J = 12 Hz, 1H), 4.64 (d, J = 11.5 Hz, 
1H), 4.59 (d, J = 12.5 Hz), 4.52 (d, J = 11.5 Hz, 1H), 4.46 (d, J = 12.5 Hz, 1H), 4.35 (d, J = 7 Hz, 1H), 4.06 
(d, J = 9.5 Hz, 1H), 3.91 (m, 1H), 3.81 (m, 3H), 3.66 (m, 2H), 3.64 (m, 1H), 3.55 (m, 1H), 3.41 (m, 2H), 
3.26 (m, 1H), 3.19 (s, 3H), 2.59 (m, 3H), 2.14 (m, 1H), 2.08-1.90 (m, 2H), 1.82-1.48 (m, 20H), 1.73 (s, 
3H), 1.37 (s, 3H), 1.32 (s, 3H), 1.26 (s, 3H), 1.18 (d, J = 7 Hz, 3H), 0.99 (d, J = 7 Hz, 3H), 0.86 (d, J = 7 
Hz, 3H); 13C NMR (CDCl3, 125MHz) δ 199.2, 149.1, 144.01, 139.0, 138.8, 136.7, 130.1, 128.3, 128.2, 
127.9, 127.8, 127.6, 127.5, 127.4, 123.1, 112.0, 108.8, 99.0, 97.9, 96.2, 83.9, 80.4, 78.6, 78.5, 75.9, 73.7, 
73.4, 72.3, 71.2, 70.9, 70.6, 68.0, 66.5, 60.4, 47.5, 46.0, 41.4, 36.0, 35.5, 34.7, 34.0, 33.1, 32.8, 32.4, 29.4, 
27.3, 27.2, 26.8, 26.2, 25.8, 25.5, 24.4, 23.0, 20.0, 19.0, 15.5, 15.4, 14.4; HRMS calcd for C69H94O13Na [M 

























 To a stirred solution of (S)-2-methyl-CBS-oxazaborolidine (180 µL of a 1.0 M solution in toluene, 0.18 
mmol) in THF (0.6 mL) at 0 °C and under N2 was added borane-tetrahydrofuran complex (140 µL of a 1 M 
solution in THF, 140 µmol) followed by a solution of 4a (16.5 mg, 14.6 µmol) in THF (0.35 mL). After 7 
min, H2O (200 µL) was added and the mixture was allowed to warm to room temperature. Diethyl ether (2 
mL) was added and the mixture was washed with 5% aqueous HCl. The aqueous phase was extracted with 
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diethyl ether (2 × 0.5 mL), and the combined organic phases were washed with H2O and saturated aqueous 
NaCl (0.5 mL ea), dried over Na2SO4, filtered, and concentrated. The crude allylic alcohol (Rf 0.40; 
hexanes−ethyl aceatate, 2:1, v/v) was filtered through silica gel with ethyl acetate, the filtrate was 
concentrated and then diluted with a mixture of THF (0.65 mL), acetic acid (0.50 mL) and H2O (0.26 mL) 
in a 10 mL vial. The vial was then capped and the reaction was heated at 55oC for 40 h before cooled to 
room temperature. The solvent was removed under vacuum and the residue was purified through column 
chromatography (hexanes-ethyl acetate, 4:1 to 2:1) to give 35a (11.6 mg, 10.8 µmol, 74%) as a white solid. 
  Rf 0.31 (hexanes-ethyl acetate, 2:1, v/v); [α]D20 = +28.4 (c 0.25, CHCl3); IR (neat): 3387, 3087, 3061, 
3023, 2953, 2925, 2864, 2854, 1491, 1455, 1379, 1250, 1206, 1078, 1026, 964, 913, 735, 698 cm-1; 1H 
NMR (CDCl3, 500 MHz): δ 7.34-7.24 (m, 15H), 5.83 (dd, J = 15.5, 7.5 Hz, 1H), 5.59 (dd, J = 15.5, 7 Hz, 
1H), 5.39 (t, J = 1.5 Hz, 1H), 5.15 (s, 1H), 5.02 (s, 1H), 4.81 (d, J = 12.5 Hz, 1H), 4.75 (d, J = 12.5 Hz, 
1H), 4.66 (d, J = 11.5 Hz, 1H), 4.61 (d, J = 12.5 Hz, 1H), 4.58 (m, 1H), 4.51 (d, J = 11.5 Hz, 1H), 4.47 (d, J 
= 12.5 Hz, 1H), 4.30 (d, J = 7 Hz, 1H), 4.11 (s, 1H), 4.02 (d, J = 9.5 Hz, 1H), 3.91 (m, 1H), 3.69-3.53 (m, 
6H), 3.37 (m, 2H), 3.24 (m, 2H), 2.54 (m, 1H), 2.44 (q, J = 7.5 Hz, 1H), 2.22-1.93 (m, 6H), 1.88−1.77 (m, 
10H), 1.73 (s, 3H), 1.69−1.30 (m, 14H), 1.16 (s, 3H), 1.04 (d, J = 7.0 Hz, 3H), 0.99 (d, J = 7.5 Hz, 3H), 
0.83 (d, J = 7.0 Hz, 3H); 13C NMR (CDCl3, 125MHz) δ 144.1, 138.8, 138.7, 138.1, 134.8, 130.9, 128.3, 
128.2, 128.2, 127.9, 127.9, 127.6, 127.5, 127.5, 122.4, 112.0, 105.5, 97.9, 96.4, 84.1, 79.0, 78.6, 77.7, 75.3, 
73.4, 73.3, 72.5, 72.4, 72.2, 71.3, 70.6, 70.4, 67.4, 60.4, 42.7, 41.0, 37.4, 36.0, 35.7, 34.0, 33.4, 33.1, 32.4, 
32.3, 31.9, 30.8, 27.0, 26.7, 25.8, 24.9, 24.7, 23.8, 23.0, 20.0, 19.0, 15.7, 15.1, 14.4; HRMS calcd for 
































dioxaspiro[5.5]undec-10-en-2-yl)-2-hydroxy-2-methylpropanoic acid (36a) 
To a stirred solution of 35a (4.5 mg, 4.2 µmol), DMSO (0.05 mL) and diisopropylethylamine (0.10 mL) in 
CH2Cl2 (0.10 mL) was added sulfur trioxide pyridine complex (5.0 mg, 31.4 µmol). The mixture was 
stirred for 2 h before saturated NH4Cl solution (1 mL) and diethyl ether (2 mL) was added. After stirring 
for another 15 min, the organic phase was separated and the aqueous phase was extracted with diethyl ether 
(4 × 1 mL). The combined organic phase was dried over Na2SO4, filtered, and concentrated. The crude 
product was dissolved in a mixture of t-butanol (0.25 mL) and water (0.05 mL) before NaH2PO4·2H2O (7 
mg, 44.9 µmol), 2-methyl-2-butene (0.2 mL) and NaClO2 (4 mg, 44.2 µmol) were added sequentially. The 
mixture was stirred for 1 h before saturated Na2S2O3 solution (1 mL) was added. The mixture was stirred 
for another 20 min before the solution was acidified to pH = 2 with 1 M HCl. The mixuture was then 
extracted with diethyl ether (6 × 1 mL) and the combined organic extract was dried over Na2SO4, filtered, 
and concentrated. Silica gel column chromatography (dichloromethane−methanol, 20:1, v/v) of the residue 
gave 36a (3.5 mg, 3.3 µmol, 78%) as a clear, colorless oil: 
  Rf 0.22 (dichloromethane-methanol, 19:1, v/v); [α]D25 = +19.2 (c 0.33, CHCl3); IR (neat): 3066, 3021, 
2924, 2853, 1738, 1713, 1462, 1378, 1180, 1078, 1027, 964, 734, 697 cm-1; 1H NMR (CDCl3, 500 MHz): δ 
7.33-7.24 (m, 15H), 5.81 (dd, J = 15.5, 7.5 Hz, 1H), 5.59 (dd, J = 15.5, 7 Hz, 1H), 5.44 (s, 1H), 5.14 (s, 
1H), 5.04  (s,1H), 4.79 (m, 2H), 4.67 (d, J = 11 Hz, 1H), 4.60 (d, J = 12.5 Hz, 1H), 4.57-4.51 (m, 2H), 4.46 
(d, J = 12.5 Hz, 1H), 4.32 (d, J = 7.5 Hz, 1H), 4.23 (brt, J = 10 Hz, 1H), 4.03 (d, J = 9.5 Hz, 1H), 3.92 (m, 
1H), 3.68-3.52 (m, 5H), 3.38 (dd, J = 11.5, 3 Hz, 1H), 3.23 (dd, J = 12, 4 Hz, 1H), 2.44 (dd, J = 14.5, 9.5 
Hz, 1H), 2.33 (q, J = 7.5 Hz, 1H), 1.73 (s, 3H), 1.39 (s, 3H), 1.07 (d, J = 7 Hz, 3H), 0.99 (d, J = 7 Hz, 3H), 
0.83 (d, J = 7 Hz, 3H); 13C NMR (CDCl3, 125MHz) δ 175.6, 143.7, 138.8, 138.7, 138.3, 130.9, 128.3, 
36
128.2, 128.2, 127.9, 127.8, 127.6, 127.5, 122.2, 112.4, 105.6, 97.9, 96.4, 84.2, 78.8, 78.4, 77.9, 75.3, 73.4, 
73.2, 72.4, 71.9, 71.3, 70.6, 66.9, 60.4, 42.7, 41.1, 37.2, 36.0, 35.6, 34.0, 33.2, 32.9, 32.3, 31.9, 30.6, 29.6, 
29.5, 29.4, 29.3, 29.1, 27.2, 27.0, 26.8, 25.8, 24.9, 24.8, 23.7, 23.0, 22.7, 20.0, 19.0, 15.8, 15.1, 14.4, 14.1; 


























dioxaspiro[5.5]undec-10-en-2-yl)-2-methylpropanoic acid (2-epi-dinophysistoxin-2) (3a, 2-epi-DTX-2) 
 To a stirred −78 °C solution of 36a (1.5 mg, 1.3 µmol) in THF (0.2 mL) under argon was added a solution 
of lithium di-tert-butylbiphenylide (0.4 mL of 0.13 M solution in THF, 0.05 mmol). After stirring for 30 
min, H2O (0.2 mL) was added to the deep blue-green solution and the resulting colorless mixture was 
allowed to warm to room temperature. The THF was removed under a stream of argon, and the residue was 
diluted with H2O (0.2 mL) and washed with hexanes (3 × 1 mL). The aqueous phase was cooled to 0 °C 
and was acidified to pH 2 with 0.5 M aqueous HCl, and extracted with diethyl ether (4 × 1 mL). The 
combined ether extracts were dried over Na2SO4, filtered, and concentrated. The residue was purified by 
silica gel column chromatography (dichloromethane-methanol, 18:1, v/v) to give 3 (0.7 mg, 0.9 µmol, 
67%) as a colorless solid. 
  Rf 0.09 (dichloromethane-methanol, 19:1, v/v); [α]D25 = +10.8 (c 0.07, CHCl3); 1H NMR (CDCl3, 500 
MHz): δ 5.78 (dd, J = 15, 8 Hz, 1H), 5.54 (dd, J = 15, 8 Hz, 1H), 5.44 (s, 1H), 5.32 (s, 1H), 5.14 (s, 1H), 
4.49 (q, J = 7 Hz, 1H), 4.21 (d, J = 10 Hz, 1H), 4.00 (m, 1H), 3.65 (m, 2H), 3.55 (m, 1H), 3.45 (dd, J = 7.5 
Hz, 1H), 3.42 (t, J = 10 Hz, 1H), 3.40 (m, 1H), 2.33 (q, J = 7 Hz, 1H), 2.23-1.30 (m, 20H), 1.77 (s, 3H), 
1.48 (s, 3H), 1.07 (d, J = 7 Hz, 3H), 0.99 (d, J = 7.5 Hz, 3H), 0.95 (d, J = 6.5 Hz, 1H); 13C NMR (CD3OD, 
125MHz) δ 147.4, 137.8, 132.0, 123.7, 112.2, 107.1, 99.3, 97.7, 86.4, 80.7, 79.5, 75.0, 73.3, 72.1, 71.4, 
37
67.0, 61.4, 38.6, 38.1, 37.4, 35.3, 34.3, 34.2, 33.3, 31.6, 28.6, 27.7, 26.7, 25.3, 23.2, 21.0, 20.1, 16.8, 14.7, 



























































































































































































































































































































































































































































































































































































































































































































































































































































































Table 1. Calculated IC50 values and relative potencies for natural OA (1), natural DTX-2 (Nat. 3), synthetic DTX-2 (Syn. 3), 
and synthetic 2-epi-DTX-2 (2-epi-3) based on PP2A and PP1 inhibition. 
PP2A PP1 
Inhibitor 
IC50 (nM) 95% Conf. Intervals Rel. Potency 
 
IC50 (nM) 95% Conf. Intervals Rel. Potency 
Nat. 1 0.47 0.40–0.54 1.000  25 18–35 1.000 
Nat. 3 0.99 0.84–1.2 0.47  76.4 58–100 0.330 
Syn. 3 1.4 1.1–1.6 0.35  82.6 55–120 0.305 
2-epi-3 140 110–180 0.003  3100 2100–4700 0.008 
 
